Natural compounds as modulators of non-apoptotic cell death in cancer cells

Current Genomics

Volumn 18, Issue 2, 2017, Pages 132-155

  Guáman Ortiz, Luis Miguel ^a   Orellana, Maria Isabel Ramirez ^a   Ratovitski, Edward A ^b  

^a UNIVERSIDAD TÉCNICA PARTICULAR DE LOJA   (Ecuador)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autophagy; Cancer; Natural compounds; Necroptosis; Paraptosis

Indexed keywords

3,4,4' TRIHYDROXY TRANS STILBENE; ALLICIN; BETULIC ACID; CANNABINOID; CELASTROL; CONCANAVALIN A; CURCUMIN; CYCLOVIROBUXINE D; EPIGALLOCATECHIN GALLATE; ERLOTINIB; GLYCYRRHETINIC ACID; HIBISCUS SABDARIFFA EXTRACT; MAMMALIAN TARGET OF RAPAMYCIN; NATURAL PRODUCT; OBLONGIFOLIN C; OMTRIPTOLIDE; ORIDONIN; PARTHENOLIDE; PLANT LECTIN; PROTEIN BAX; PTEROSTILBENE; RESVERATROL; SERINIQUINONE; SESQUITERPENE LACTONE; SULFORAPHANE; TERPENOID; THYMOQUINONE; TRIPTOLIDE; TUMOR PROTEIN P73; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTOCARPUS HETEROPHYLLUS; AUTOPHAGOSOME; AUTOPHAGY; CELL DEATH; CELL VIABILITY; CHINESE MEDICINE; CLINICAL TRIAL (TOPIC); DOWN REGULATION; DRUG RESISTANCE; GENE SILENCING; HERBAL MEDICINE; HUMAN; NECROPTOSIS; NEUROBLASTOMA; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TRANSMISSION ELECTRON MICROSCOPY; TUBEROUS SCLEROSIS; UPREGULATION;

EID: 85013959545     PISSN: 13892029     EISSN: 18755488     Source Type: Journal    
DOI: 10.2174/1389202917666160803150639     Document Type: Review

References (343)

1. Hanahan, D.; Weinberg, R.A. The hallmarks of cancer. Cell, 2000, 100(1), 57-70.
2. Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: the next generation. Cell, 2011, 144(5), 646-674.
3. Goodson, W.H. 3rd; Lowe, L.; Carpenter, D.O.; Gilbertson, M.; Manaf Ali, A.; Lopez de Cerain Salsamendi, A.; Lasfar, A.; Carnero, A.; Azqueta, A.; Amedei, A.; Charles, A.K.; Collins, A.R.; Ward, A.; Salzberg, A.C.; Colacci, A.; Olsen, A.K.; Berg, A.; Barclay, B.J.; Zhou, B.P.; Blanco-Aparicio, C.; Baglole, C.J.; Dong, C.; Mondello, C.; Hsu, C.W.; Naus, C.C.; Yedjou, C.; Curran, C.S.; Laird, D.W.; Koch, D.C.; Carlin, D.J.; Felsher, D.W.; Roy, D.; Brown, D.G.; Ratovitski, E.; Ryan, E.P.; Corsini, E.; Rojas, E.; Moon, E.Y.; Laconi, E.; Marongiu, F.; Al-Mulla, F.; Chiaradonna, F.; Darroudi, F.; Martin, F.L.; Van Schooten, F.J.; Goldberg, G.S.; Wagemaker, G.; Nangami, G.N.; Calaf, G.M.; Williams, G.; Wolf, G.T.; Koppen, G.; Brunborg, G.; Lyerly, H.K.; Krishnan, H.; Ab Hamid, H.; Yasaei, H.; Sone, H.; Kondoh, H.; Salem, H.K.; Hsu, H.Y.; Park, H.H.; Koturbash, I.; Miousse, I.R.; Scovassi, A.I.; Klaunig, J.E.; Vondraček, J.; Raju, J.; Roman, J.; Wise, J.P. Sr; Whitfield, J.R.; Woodrick, J.; Christopher, J.A.; Ochieng, J.; Martinez-Leal, J.F.; Weisz, J.; Kravchenko, J.; Sun, J.; Prudhomme, K.R.; Narayanan, K.B.; Cohen-Solal, K.A.; Moorwood, K.; Gonzalez, L.; Soucek, L.; Jian, L.; D’Abronzo, L.S.; Lin, L.T.; Li, L.; Gulliver, L.; McCawley, L.J.; Memeo, L.; Vermeulen, L.; Leyns, L.; Zhang, L.; Valverde, M.; Khatami, M.; Romano, M.F.; Chapellier, M.; Williams, M.A.; Wade, M.; Manjili, M.H.; Lleonart, M.E.; Xia, M.; Gonzalez, M.J.; Karamouzis, M.V.; Kirsch-Volders, M.; Vaccari, M.; Kuemmerle, N.B.; Singh, N.; Cruickshanks, N.; Kleinstreuer, N.; van Larebeke, N.; Ahmed, N.; Ogunkua, O.; Krishnakumar, P.K.; Vadgama, P.; Marignani, P.A.; Ghosh, P.M.; Ostrosky-Wegman, P.; Thompson, P.A.; Dent, P.; Heneberg, P.; Darbre, P.; Sing Leung, P.; Nangia-Makker, P.; Cheng, Q.S.; Robey, R.B.; Al-Temaimi, R.; Roy, R.; Andrade-Vieira, R.; Sinha, R.K.; Mehta, R.; Vento, R.; Di Fiore, R.; Ponce-Cusi, R.; Dornetshuber-Fleiss, R.; Nahta, R.; Castellino, R.C.; Palorini, R.; Abd Hamid, R.; Langie, S.A.; Eltom, S.E.; Brooks, S.A.; Ryeom, S.; Wise, S.S.; Bay, S.N.; Harris, S.A.; Papagerakis, S.; Romano, S.; Pavanello, S.; Eriksson, S.; Forte, S.; Casey, S.C.; Luanpitpong, S.; Lee, T.J.; Otsuki, T.; Chen, T.; Massfelder, T.; Sanderson, T.; Guarnieri, T.; Hultman, T.; Dormoy, V.; Odero-Marah, V.; Sabbisetti, V.; Maguer-Satta, V.; Rathmell, W.K.; Engstrom, W.; Decker, W.K.; Bisson, W.H.; Rojanasakul, Y.; Luqmani, Y.; Chen, Z.; Hu, Z. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead. Carcinogenesis, 2015, 36 (Suppl 1), S254-96
4. Narayanan, K.B.; Ali, M.; Barclay, B.J.; Cheng, Q.S.; D’Abronzo, L.; Dornetshuber-Fleiss, R.; Ghosh, P.M.; Gonzalez Guzman, M.J.; Lee, T.J.; Leung, P.S.; Li, L.; Luanpitpong, S.; Ratovitski, E.; Rojanasakul, Y.; Romano, M.F.; Romano, S.; Sinha, R.K.; Yedjou, C.; Al-Mulla, F.; Al-Temaimi, R.; Amedei, A.; Brown, D.G.; Ryan, E.P.; Colacci, A.; Hamid, R.A.; Mondello, C.; Raju, J.; Salem, H.K.; Woodrick, J.; Scovassi, A.I.; Singh, N.; Vaccari, M.; Roy, R.; Forte, S.; Memeo, L.; Kim, S.Y.; Bisson, W.H.; Lowe, L.; Park, H.H. Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death. Carcinogenesis, 2015, 36 (Suppl 1), S89-110.
5. Hu, Z.; Brooks, S.A.; Dormoy, V.; Hsu, C.W.; Hsu, H.Y.; Lin, L.T.; Massfelder, T.; Rathmell, W.K.; Xia, M.; Al-Mulla, F.; Al-Temaimi, R.; Amedei, A.; Brown, D.G.; Prudhomme, K.R.; Colacci, A.; Hamid, R.A.; Mondello, C.; Raju, J.; Ryan, E.P.; Woodrick, J.; Scovassi, A.I.; Singh, N.; Vaccari, M.; Roy, R.; Forte, S.; Memeo, L.; Salem, H.K.; Lowe, L.; Jensen, L.; Bisson, W.H.; Kleinstreuer, N. Assessing the carcinogenic potential of lowdose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis. Carcinogenesis, 2015, 36 Suppl 1, S184-202.
6. Thompson, P.A.; Khatami, M.; Baglole, C.J.; Sun, J.; Harris, S.A.; Moon, E.Y.; Al-Mulla, F.; Al-Temaimi, R.; Brown, D.G.; Colacci, A.; Mondello, C.; Raju, J.; Ryan, E.P.; Woodrick, J.; Scovassi, A.I.; Singh, N.; Vaccari, M.; Roy, R.; Forte, S.; Memeo, L.; Salem, H.K.; Amedei, A.; Hamid, R.A.; Lowe, L.; Guarnieri, T.; Bisson, W.H. Environmental immune disruptors, inflammation and cancer risk. Carcinogenesis, 2015, 36 Suppl 1, S232-253.
7. Robey, R.B.; Weisz, J.; Kuemmerle, N.B.; Salzberg, A.C.; Berg, A.; Brown, D.G.; Kubik, L.; Palorini, R.; Al-Mulla, F.; Al-Temaimi, R.; Colacci, A.; Mondello, C.; Raju, J.; Woodrick, J.; Scovassi, A.I.; Singh, N.; Vaccari, M.; Roy, R.; Forte, S.; Memeo, L.; Salem, H.K.; Amedei, A.; Hamid, R.A.; Williams, G.P.; Lowe, L.; Meyer, J.; Martin, F.L.; Bisson, W.H.; Chiaradonna, F.; Ryan, E.P. Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis? Carcinogenesis, 2015, 36 Suppl 1, S203-231.
8. Kravchenko, J.; Corsini, E.; Williams, M.A.; Decker, W.; Manjili, M.H.; Otsuki, T.; Singh, N.; Al-Mulla, F.; Al-Temaimi, R.; Amedei, A.; Colacci, A.M.; Vaccari, M.; Mondello, C.; Scovassi, A.I.; Raju, J.; Hamid, R.A.; Memeo, L.; Forte, S.; Roy, R.; Woodrick, J.; Salem, H.K.; Ryan, E.P.; Brown, D.G.; Bisson, W.H.; Lowe, L.; Lyerly, H.K. Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactions. Carcinogenesis, 2015, 36 Suppl 1, S111-127.
9. Langie, S.A.; Koppen, G.; Desaulniers, D.; Al-Mulla, F.; Al-Temaimi, R.; Amedei A.; Azqueta A.; Bisson, W.H.; Brown, D.G.; Brunborg, G.; Charles, A.K.; Chen, T.; Colacci, A.; Darroudi, F.; Forte, S.; Gonzalez, L.; Hamid, R.A.; Knudsen, L.E.; Leyns, L.; Lopez de Cerain Salsamendi, A.; Memeo, L.; Mondello, C.; Mothersill, C.; Olsen, A.K.; Pavanello, S.; Raju, J.; Rojas, E.; Roy, R.; Ryan, E.P.; Ostrosky-Wegman, P.; Salem, H.K.; Scovassi, A.I.; Singh, N.; Vaccari, M.; Van Schooten, F.J.; Valverde, M.; Woodrick, J.; Zhang, L.; van Larebeke, N.; Kirsch-Volders, M.; Collins, A.R. Causes of genome instability: the effect of low dose chemical exposures in modern society. Carcinogenesis, 2015, 36 Suppl 1, S61-88.
10. Engstrom, W.; Darbre, P.; Eriksson, S.; Gulliver, L.; Hultman, T.; Karamouzis, M.V.; Klaunig, J.E.; Mehta, R.; Moorwood, K.; Sanderson, T.; Sone, H.; Vadgama, P.; Wagemaker, G.; Ward, A.; Singh, N.; Al-Mulla, F.; Al-Temaimi, R.; Amedei, A.; Colacci, A.M.; Vaccari, M.; Mondello, C.; Scovassi, A.I.; Raju, J.; Hamid, R.A.; Memeo, L.; Forte, S.; Roy, R.; Woodrick, J.; Salem, H.K.; Ryan, E.P.; Brown, D.G.; Bisson, W.H. The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling. Carcinogenesis, 2015, 36 Suppl 1, S38-60.
11. Nahta, R.; Al-Mulla, F.; Al-Temaimi, R.; Amedei, A.; Andrade-Vieira, R.; Bay, S.N.; Brown, D.G.; Calaf, G.M.; Castellino, R.C.; Cohen-Solal, K.A.; Colacci, A.; Cruickshanks, N.; Dent, P.; Di Fiore, R.; Forte, S.; Goldberg, G.S.; Hamid, R.A.; Krishnan, H.; Laird, D.W.; Lasfar, A.; Marignani, P.A.; Memeo, L.; Mondello, C.; Naus, C.C.; Ponce-Cusi, R.; Raju, J.; Roy, D.; Roy, R.; Ryan, E.P.; Salem, H.K.; Scovassi, A.I.; Singh, N.; Vaccari, M.; Vento, R.; Vondraček, J.; Wade, M.; Woodrick, J.; Bisson, W.H. Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression. Carcinogenesis, 2015, 36 Suppl 1, S2-18.
12. Carnero, A.; Blanco-Aparicio, C.; Kondoh, H.; Lleonart, M.E.; Martinez-Leal, J.F.; Mondello, C.; Scovassi, A.I.; Bisson, W.H.; Amedei, A.; Roy, R.; Woodrick, J.; Colacci, A.; Vaccari, M.; Raju, J.; Al-Mulla, F.; Al-Temaimi, R.; Salem, H.K.; Memeo, L.; Forte, S.; Singh, N.; Hamid, R.A.; Ryan, E.P.; Brown, D.G.; Wise, J.P. Sr; Wise, S.S.; Yasaeim H. Disruptive chemicals, senescence and immortality. Carcinogenesis, 2015, 36 Suppl 1, S19-37.
13. Casey, S.C.; Vaccari, M.; Al-Mulla, F.; Al-Temaimi, R.; Amedei, A.; Barcellos-Hoff, M.H.; Brown, D.G.; Chapellier, M.; Christopher, J.; Curran, C.S.; Forte, S.; Hamid, R.A.; Heneberg, P.; Koch, D.C.; Krishnakumar, P.K.; Laconi, E.; Maguer-Satta, V.; Marongiu, F.; Memeo, L.; Mondello, C.; Raju, J.; Roman, J.; Roy, R.; Ryan, E.P.; Ryeom, S.; Salem, H.K.; Scovassi, A.I.; Singh, N.; Soucek, L.; Vermeulen, L.; Whitfield, J.R.; Woodrick, J.; Colacci A(2), Bisson WH(25), Felsher DW(26). The effect of environmental chemicals on the tumor microenvironment. Carcinogenesis, 2015, 36 Suppl 1, S160-183.
14. Ochieng, J.; Nangami, G.N.; Ogunkua, O.; Miousse, I.R.; Koturbash, I.; Odero-Marah, V.; McCawley, L.J.; Nangia-Makker, P.; Ahmed, N.; Luqmani, Y.; Chen, Z.; Papagerakis, S.; Wolf, G.T.; Dong, C.; Zhou, B.P.; Brown, D.G.; Colacci, A.M.; Hamid, R.A.; Mondello, C.; Raju, J.; Ryan, E.P.; Woodrick, J.; Scovassi, A.I.; Singh, N.; Vaccari, M.; Roy, R.; Forte, S.; Memeo, L.; Salem, H.K.; Amedei, A.; Al-Temaimi, R.; Al-Mulla, F.; Bisson, W.H.; Eltom, S.E. The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis. Carcinogenesis, 2015, 36 Suppl 1, S128-159.
15. Hu, X.; Xuan, Y. Bypassing cancer drug resistance by activating multiple death pathways-a proposal from the study of circumventing cancer drug resistance by induction of necroptosis. Cancer Lett., 2008, 259(2), 127-137.
16. Fuchs, Y.; Steller, H. Live to die another way: modes of programmed cell death and the signals emanating from dying cells. Nat. Rev. Mol. Cell Biol., 2015, 16(6), 329-344.
17. Mohammad, R.M.; Muqbil, I.; Lowe, L.; Yedjou, C.; Hsu, H.Y.; Lin, L.T.; Siegelin, M.D.; Fimognari, C.; Kumar, N.B.; Dou, QP.; Yang, H.; Samadi, A.K.; Russo, G.L.; Spagnuolo, C.; Ray, S.K.; Chakrabarti, M.; Morre, J.D.; Coley, H.M.; Honoki, K.; Fujii, H.; Georgakilas, A.G.; Amedei, A.; Niccolai, E.; Amin, A.; Ashraf, S.S.; Helferich, W.G.; Yang, X.; Boosani, C.S.; Guha, G.; Bhakta, D.; Ciriolo, M.R.; Aquilano, K.; Chen, S.; Mohammed, S.I.; Keith, W.N.; Bilsland, A.; Halicka, D.; Nowsheen, S.; Azmi, A.S. Broad targeting of resistance to apoptosis in cancer. Semin. Cancer Biol., 2015, Apr 28.
18. Su, Z.; Yang, Z.; Xu, Y.; Chen, Y.; Yu, Q. Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol. Cancer, 2015, 14, 48.
19. Lalaoui, N.; Lindqvist, L.M.; Sandow, J.J.; Ekert, P.G. The molecular relationships between apoptosis, autophagy and necroptosis. Semin. Cell Dev. Biol., 2015, 39, 63-69.
20. Radogna, F.; Dicato, M.; Diederich, M. Cancer-type-specific crosstalk between autophagy, necroptosis and apoptosis as a pharmacological target. Biochem. Pharmacol., 2015, 94(1), 1-11.
21. Tait, S.W.; Ichim, G.; Green, D.R. Die another way-non-apoptotic mechanisms of cell death. J. Cell Sci., 2014, 127(Pt 10), 2135-2144.
22. Nikoletopoulou, V.; Markaki, M.; Palikaras, K.; Tavernarakis, N. Crosstalk between apoptosis, necrosis and autophagy. Biochim. Biophys. Acta, 2013, 1833(12), 3448-3459.
23. Long, J.S.; Ryan, K.M. New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy. Oncogene, 2012, 31(49), 5045-5060.
24. Zhang S.F.; Wang, X.L.; Yang, X.Q.; Chen, N. Autophagyassociated targeting pathways of natural compounds during cancer treatment. Asian Pac. J. Cancer Prev., 2014, 15(24), 10557-10563.
25. Kim, J.; Park, E.J. Cytotoxic anticancer candidates from natural resources. Curr. Med. Chem. Anticancer Agents, 2002, 2, 485-537.
26. Kinghorn, A.D.; Chin, Y.W.; Swanson, S.M. Discovery of natural product anticancer agents from biodiverse organisms. Curr. Opin. Drug Discov. Devel., 2009, 12, 189-96.
27. Meiyanto, E.; Hermawan, A.; Anindyajati. Natural compounds for cancer-targeted therapy: citrus flavonoids as potent chemopreventive agents. Asian Pac. J. Cancer Prev., 2012, 13, 427-36.
28. Wang, N.; Feng, Y. Elaborating the role of natural compoundsinduced autophagy in cancer treatment: achievements and artifacts in the state of the art. Biomed. Res. Int., 2015, 2015, 934207.
29. Gali-Muhtasib, H.; Hmadi, R.; Kareh, M.; Tohme, R.; Darwiche, N. Cell death mechanisms of plant-derived anticancer drugs: beyond apoptosis. Apoptosis, 2015, Sep 11.
30. Levine, B.; Kroemer, G. Autophagy in the pathogenesis of disease. Cell, 2008, 132, 27-42.
31. Mizushima, N. The role of the Atg1/ULK1 complex in autophagy regulation. Curr. Opin. Cell Biol., 2010, 22, 132-139.
32. Mizushima, N.; Yoshimori, T.; Ohsumi, Y. The role of Atg proteins in autophagosome formation. Annu. Rev. Cell Dev. Biol., 2011, 27, 107-132.
33. Yang, Z.; Klionsky, D.J. Eaten alive: a history of macroautophagy. Nat. Cell Biol., 2010, 12, 814-822.
34. Vandenabeele, P.; Galluzzi, L.; Vanden Berghe, T.; Kroemer, G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat. Rev. Mol. Cell Biol., 2010, 11 (10): 700-714.
35. Galluzzi, L.; Kepp, O.; Krautwald, S.; Kroemer, G.; Linkermann, A. Molecular mechanisms of regulated necrosis. Semin. Cell Dev. Biol., 2014, 35, 24-32.
36. Zhou, W; Yuan, J. Necroptosis in health and diseases. Semin. Cell Dev. Biol., 2014, 35, 14-23.
37. Luo, X.; Yu, X.; Liu, S.; Deng, Q.; Liu, X.; Peng, S.; Li, H.; Liu, J.; Cao, Y. The role of targeting kinase activity by natural compounds in cancer chemoprevention and chemotherapy. Oncol. Rep., 2015, 34(2), 547-554.
38. Barrera, L.N.; Cassidy, A.; Johnson, I.T.; Bao, Y.; Belshaw, N.J. Epigenetic and antioxidant effects of dietary isothiocyanates and selenium: potential implications for cancer chemoprevention. Proc. Nutr. Soc., 2012, 71(2), 237-245.
39. Shen, M.; Chan, T.H.; Dou, Q.P. Targeting tumor ubiquitinproteasome pathway with polyphenols for chemosensitization. Anticancer Agents Med. Chem., 2012, 12(8), 891-901.
40. Cerella, C.; Dicato, M.; Jacob, C.; Diederich, M. Chemical properties and mechanisms determining the anti-cancer action of garlicderived organic sulfur compounds. Anticancer Agents Med. Chem., 2011, 11(3), 267-271.
41. Huang, J.; Plass, C.; Gerhauser, C. Cancer chemoprevention by targeting the epigenome. Curr. Drug Targets, 2011, 12(13), 1925-1956.
42. Fulda, S. Modulation of apoptosis by natural compounds for cancer therapy. Planta Med., 2010, 76(11), 1075-1079.
43. Wang, S.; Penchala, S.; Prabhu, S.; Wang, J.; Huang, Y. Molecular basis of traditional Chinese medicine in cancer chemoprevention. Curr. Drug Discov. Technol., 2010, 7(1), 67-75.
44. Sarkar, F.H.; Li, Y. Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics. Cancer Treat Rev., 2009, 35(7), 597-607.
45. Wang, X.; Feng, Y.; Wang, N.; Cheung, F.; Tan, H.Y.; Zhong, S.; Li, C.; Kobayashi, S. Chinese medicines induce cell death: the molecular and cellular mechanisms for cancer therapy. Biomed. Res. Int., 2014, 2014, 530342.
46. Zhou, M.; Wang, R. Small-molecule regulators of autophagy and their potential therapeutic applications. Chem. Med. Chem., 2013, 8(5), 694-707.
47. Sun, H.; Wang, Z.; Yakisich, J.S. Natural compounds targeting autophagy via the PI3K/Akt/mTOR pathway as anticancer agents. Anticancer Agents Med. Chem., 2013, 13(7), 1048-1056.
48. Mukhtar, E.; Adhami, V.M.; Khan, N.; Mukhtar, H. Apoptosis and autophagy induction as mechanism of cancer prevention by naturally occurring dietary agents. Curr. Drug Targets, 2012, 13(14), 1831-1841.
49. Zhang, X.; Chen, L.X.; Ouyang, L.; Cheng, Y.; Liu, B. Plant natural compounds: targeting pathways of autophagy as anti-cancer therapeutic agents. Cell Prolif., 2012, 45(5), 466-476.
50. Kroemer, G.; Marino, G.; Levine, B. Autophagy and the integrated stress response. Mol. Cell, 2010, 40(2), 280-293.
51. Chen, N.; Karantza-Wadsworth, V. Role and regulation of autophagy in cancer. Biochim. Biophys. Acta, 2009, 1793, 1516-1523.
52. Chen, N.; Karantza, V. Autophagy as a therapeutic target in cancer. Cancer Biol. Ther., 2011, 11, 157-168.
53. Wesselborg, S.; Stork, B. Autophagy signal transduction by ATG proteins: from hierarchies to networks. Cell Mol. Life Sci., 2015, Sep 21.
54. Khalfan, W.A.; Klionsky, D.J. Molecular machinery required for autophagy and the cytoplasm to vacuole targeting (Cvt) pathway in S. cerevisiae. Curr. Opin. Cell Biol., 2002, 14(4), 468-475.
55. Yorimitsu, T.; Klionsky, D.J. Autophagy: molecular machinery for self-eating. Cell Death Differ., 2005, 12 Suppl 2,1542-1552.
56. Codogno, P.; Meijer, A.J. Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ., 2005, 12 Suppl 2, 1509-1518.
57. Xie, Z.; Klionsky, D.J. Autophagosome formation: core machinery and adaptations. Nat. Cell Biol., 2007, 9(10), 1102-1109.
58. Maiuri, M.C.; Zalckvar, E.; Kimchi, A.; Kroemer, G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell Biol., 2007, 8(9), 741-745.
59. Frankel, L.B.; Lund, A.H. MicroRNA regulation of autophagy. Carcinogenesis, 2012, 33(11), 2018-2025.
60. Romanov, J.; Walczak, M.; Ibiricu I.; Schuchner, S.; Ogris, E., Kraft, C.; Martens, S. Mechanism and functions of membrane binding by the Atg5-Atg12/Atg16 complex during autophagosome formation. EMBO J., 2012, 31, 4304-4317.
61. Satoo, K.; Noda, N.N.; Kumeta, H.; Fujioka, Y.; Mizushima, N.; Ohsumi, Y.; Inagaki, F. The structure of Atg4B-LC3 complex reveals the mechanism of LC3 processing and delipidation during autophagy. EMBO J., 2009, 28, 1341-1350.
62. Degenhardt, K.; Mathew, R.; Beaudoin, B.; Bray, K.; Anderson, D.; Chen, G.; Mukherjee, C.; Shi, Y.; Gelinas, C.; Fan, Y.; Nelson, D.A.; Jin, S.; White, E. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell, 2006, 10, 51-64.
63. Mathew, R.; Karp, C.M.; Beaudoin, B.; Vuong, N.; Chen, G.; Chen, H.Y.; Bray, K.; Reddy, A.; Bhanot, G.; Gelinas, C.; Dipaola, R.S.; Karantza-Wadsworth, V.; White, E. Autophagy suppresses tumorigenesis through elimination of p62. Cell, 2009, 137, 1062-1075.
64. Galluzzi, L.; Pietrocola, F.; Bravo-San Pedro, J.M.; Amaravadi, R.K.; Baehrecke, E.H.; Cecconi, F.; Codogno, P.; Debnath, J.; Gewirtz, D.A.; Karantza, V.; Kimmelman, A.; Kumar, S.; Levine, B.; Maiuri, M.C.; Martin, S.J.; Penninger, J.; Piacentini, M.; Rubinsztein, D.C.; Simon, H.U.; Simonsen, A.; Thorburn, A.M.; Velasco, G.; Ryan, K.M.; Kroemer, G. Autophagy in malignant transformation and cancer progression. EMBO J., 2015, 34(7), 856-880.
65. Panda, P.K.; Mukhopadhyay, S.; Das, D.N.; Sinha, N.; Naik, P.P.; Bhutia S.K. Mechanism of autophagic regulation in carcinogenesis and cancer therapeutics. Semin. Cell. Dev. Biol., 2015, 39, 43-55.
66. Qu, X.; Yu, J.; Bhagat, G.; Furuya, N.; Hibshoosh, H.; Troxel, A.; Rosen, J.; Eskelinen, E.L.; Mizushima, N.; Ohsumi, Y.; Cattoretti, G.; Levine, B. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest., 2003, 112, 1809-1820.
67. Laddha, S.V.; Ganesan, S.; Chan, C.S.; White, E. Mutational landscape of the essential autophagy gene BECN1 in human cancers. Mol. Cancer Res., 2014, 12(4), 485-490.
68. Guerrero-Preston, R.; Ratovitski, E.A. Chapter XVII: “Cisplatin Exposure of Squamous Cell Carcinoma Cells leads to the Modulation of Autophagic pathway”. pp. 251-267. Molecular Mechanisms. Volume I. In: AUTOPHAGY: Cancer, Other Pathologies, Inflammation, Immunity, and Infection. Edited by M. A. Hayat. Elsevier Publishing Company, 2013. ISBN: 978-0-12-405530-8.
69. Borst, P.; Rottenberg, S.; Jonkers, J. How do real tumors become resistant to cisplatin? Cell Cycle, 2008, 7, 1353-1359.
70. Kaushal, G.P.; Kaushal, V.; Herzog, C.; Yang, C. Autophagy delays apoptosis in renal tubular epithelial cells in cisplatin cytotoxicity. Autophagy, 2008, 4, 710-712.
71. O’Donovan, T.R.; O’Sullivan, G.C.; McKenna, S.L. Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics. Autophagy, 2011, 7, 509-524.
72. Zhang, Y.; Cheng, Y.; Ren, X.; Zhang, L.; Yap, K.L.; Wu, H.; Patel, R.; Liu, D.; Qin, Z.H.; Shih, I.M.; Yang, J.M. NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response. Oncogene, 2012, 31, 1055-1064.
73. Huang, J.; Liu, K.; Yu, Y.; Xie, M.; Kang, R.; Vernon, P.; Cao, L.; Tang, D.; Ni, J. Targeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcoma. Autophagy, 2012, 8, 275-277.
74. Wyrsch, P.; Blenn, C.; Bader, J.; lthaus, F.R. Cell death and autophagy under oxidative stress: roles of poly (ADP-Ribose) polymerases and Ca (2+). Mol. Cell. Biol., 2012, 32, 3541-3553.
75. Harhaji-Trajkovic, L.; Vilimanovich, U.; Kravic-Stevovic, T.; Bumbasirevic, V.; Trajkovic, V. AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumour cells. J. Cell. Mol. Med., 2009, 13, 3644-3654.
76. Huang, Y.; Ratovitski, E.A. Phospho-ΔNp63α/Rpn13-dependent regulation of LKB1 degradation modulates autophagy in cancer cells. Aging, 2010, 2, 959-968.
77. Huang, Y.P.; Guerrero-Preston, R.; Ratovitski, E.A. Phospho-ΔNp63α-dependent regulation of autophagic signaling through transcription and miRNA modulation. Cell Cycle, 2012, 11, 1247-1259.
78. Ryan, K.M. p53 and autophagy in cancer: guardian of the genome meets guardian of the proteome. Eur. J. Cancer, 2011, 47, 44-50.
79. Sui, X.; Jin, L.; Huang, X.; Geng, S.; He, C.; Hu, X. p53 signaling and autophagy in cancer: a revolutionary strategy could be developed for cancer treatment. Autophagy, 2011, 7, 565-571.
80. Crighton, D.; Wilkinson, S.; O’Prey, J.; Syed, N.; Smith, P.; Harrison, P.R.; Gasco, M.; Garrone, O.; Crook, T.; Ryan, K.M. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell, 2006, 126, 121-134.
81. Crighton, D.; O’Prey, J.; Bell, H.S.; Ryan, K.M. p73 regulates DRAM-independent autophagy that does not contribute to programmed cell death. Cell Death Differ., 2007, 14, 1071-1079.
82. Eby, K.G.; Rosenbluth, J.M.; Mays, D.J.; Marshall, C.B.; Barton, C.E.; Sinha, S.; Johnson, K.N.; Tang, L.; Pietenpol, J.A. ISG20L1 is a p53 family target gene that modulates genotoxic stress-induced autophagy. Mol. Cancer., 2010, 9, 95.
83. Maiuri, M.C.; Malik, S.A.; Morselli, E.; Kepp, O.; Criollo, A.; Mouchel, P.L.; Carnuccio, R.; Kroemer, G. Stimulation of autophagy by the p53 target gene Sestrin2. Cell Cycle, 2009, 8, 1571-1576.
84. Tasdemir, E.; Maiuri, M.C.; Galluzzi, L.; Vitale, I.; Djavaheri-Mergny, M.; D’Amelio, M.; Criollo, A.; Morselli, E.; Zhu, C.; Harper, F.; Nannmark, U.; Samara, C.; Pinton, P.; Vicencio, J.M.; Carnuccio, R.; Moll, U.M.; Madeo, F.; Paterlini-Brechot, P.; Rizzuto, R.; Szabadkai, G.; Pierron, G.; Blomgren, K.; Tavernarakis, N.; Codogno, P.; Cecconi, F.; Kroemer, G. Regulation of autophagy by cytoplasmic p53. Nat. Cell Biol., 2008, 10, 676-687.
85. Kenzelmann Broz, D.; Attardi, L.D. TP53 activates a global autophagy program to promote tumor suppression. Autophagy, 2013, 9(9), 1440-1442.
86. Kenzelmann Broz, D.; Spano Mello, S.; Bieging, K.T.; Jiang, D.; Dusek, R.L.; Brady, C.A.; Sidow, A.; Attardi, L.D. Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses. Genes Dev., 2013, 27(9), 1016-1031.
87. Kusama, Y.; Sato, K.; Kimura, N.; Mitamura, J.; Ohdaira, H.; Yoshida, K. Comprehensive analysis of expression pattern and promoter regulation of human autophagy-related genes. Apoptosis, 2009, 14, 1165-1175.
88. Maiuri, M.C.; Criollo, A.; Kroemer, G. Crosstalk between apoptosis and autophagy within the Beclin 1 interactome. EMBO J., 2010, 29, 515-611.
89. Alexander, A.; Cai, S.L.; Kim, J.; Nanez, A.; Sahin, M.; MacLean, K.H.; Inoki, K.; Guan, K.L.; Shen, J.; Person, M.D.; Kusewitt, D.; Mills, G.B.; Kastan, M.B.; Walker, C.L. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc. Natl. Acad. Sci. U. S. A., 2010, 107, 4153-4158.
90. Rosenbluth, J.M.; Pietenpol, J.A. mTOR regulates autophagyassociated genes downstream of p73. Autophagy, 2009, 5, 114-116.
91. Hibi, K.; Trink, B.; Patturajan, M.; Westra, W.H.; Caballero, O.L.; Hill, D.E.; Ratovitski, E.A.; Jen, J.; Sidransky, D. AIS is an oncogene amplified in squamous cell carcinoma. Proc. Natl. Acad. Sci. U. S. A., 2000, 97(10), 5462-5467.
92. Pandey, S.; Chandravati. Autophagy in cervical cancer: an emerging therapeutic target. Asian Pac. J. Cancer Prev., 2012, 13, 4867-4871.
93. Rikiishi, H. Autophagic action of new targeting agents in head and neck oncology. Cancer Biol. Ther. 2012, 13, 978-991.
94. Balunas, M.J.; Kinghorn, A.D. Drug discovery from medicinal plants. Life Sci., 2005, 78, 431-441.
95. Kinghorn, A.D.; Carcache de Blanco, E.J.; Chai, H.B.; Orjala, J.; Farnsworth, N.R.; Soejarto, D.D.; Oberlies, N.H.; Wani, M.C.; Kroll, D.J.; Pearce, C.J.; Swanson, S.M.; Kramer, R.A.; Rose, W.C.; Fairchild, C.R.; Vite, G.D.; Emanuel, S.; Jarjoura, D.; Cope, F.O. Discovery of anticancer agents of diverse natural origin. Pure Appl. Chem., 2009, 81(6), 1051-1063.
96. Guaman-Ortiz, L.M.; Lombardi, P.; Tillhon, M.; Scovassi, A.I. Berberine, an epiphany against cancer. Molecules, 2014, 19(8), 12349-12367.
97. Guaman-Ortiz, L.M.; Croce, A.L.; Aredia, F.; Sapienza, S.; Fiorillo, G.; Syeda, T.M.; Buzzetti, F.; Lombardi, P.; Scovassi, A.I. Effect of new berberine derivatives on colon cancer cells. Acta Biochim. Biophys. Sin. (Shanghai), 2015, 47(10), 824-833.
98. Lee, K.H.; Lo, H.L.; Tang, W.C.; Hsiao, H.H.; Yang, P.M. A gene expression signature-based approach reveals the mechanisms of action of the Chinese herbal medicine berberine. Sci. Rep., 2014, 4, 6394.
99. Guaman-Ortiz, L.M.; Tillhon, M.; Parks, M.; Dutto, I.; Prosperi, E.; Savio, M.; Arcamone, A.G.; Buzzetti, F.; Lombardi, P.; Scovassi, A.I. Multiple effects of berberine derivatives on colon cancer cells. Biomed. Res. Int., 2014, 2014, 924585.
100. Yu, R.; Zhang, Z.Q.; Wang, B.; Jiang, H.X.; Cheng, L.; Shen, L.M. Berberine-induced apoptotic and autophagic death of HepG2 cells requires AMPK activation. Cancer Cell Int., 2014, 14, 49.
101. Wang, N.; Feng, Y.; Zhu, M.; Tsang, C.M.; Man, K.; Tong, Y.; Tsao, S.W. Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism. J. Cell Biochem., 2010, 111(6), 1426-1436.
102. Tillhon, M.; Guaman-Ortiz, L.M.; Lombardi, P.; Scovassi, A.I. Berberine: new perspectives for old remedies. Biochem. Pharmacol., 2012, 84(10), 1260-1267.
103. Peng, P.L.; Kuo, W.H.; Tseng, H.C.; Chou, F.P. Synergistic tumorkilling effect of radiation and berberine combined treatment in lung cancer: the contribution of autophagic cell death. Int. J. Radiat. Oncol. Biol. Phys., 2008, 70(2), 529-542.
104. Aredia, F.; Guaman-Ortiz, L.M.; Giansanti, V.; Scovassi, A.I. Autophagy and cancer. Cells, 2012, 1(3), 520-534.
105. Tyihak, E.; Kiraly-Veghely, Z.; Moricz, A.M. Multiple beneficial effects of resveratrol and their chemical-biochemical basis. Nat. Prod. Commun., 2011, 6(5), 631-638.
106. Szende, B.; Tyihak, E.; Kiraly-Veghely, Z. Dose-dependent effect of resveratrol on proliferation and apoptosis in endothelial and tumor cell cultures. Exp. Mol. Med., 2000, 32(2), 88-92.
107. Kiraly-Veghely, Z.; Tyihak, E.; Albert, L.; Nemeth, Z.I.; Katay, G. Identification and measurement of resveratrol and formaldehyde in parts of white and blue grape berries. Acta Biol. Hung., 1998, 49(2-4), 281-289.
108. Aras, A.; Khokhar, A.R.; Qureshi, M.Z.; Silva, M.F.; Sobczak-Kupiec, A.; Pineda, E.A.; Hechenleitner, A.A.; Farooqi, A.A. Targeting cancer with nano-bullets: curcumin, EGCG, resveratrol and quercetin on flying carpets. Asian Pac. J. Cancer Prev., 2014, 15(9), 3865-3871.
109. Jang, M.; Cai, L.; Udeani, G.O.; Slowing, K.V.; Thomas, C.F.; Beecher, C.W.; Fong, H.H.; Farnsworth, N.R.; Kinghorn, A.D.; Mehta, R.G.; Moon, R.C.; Pezzuto, J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 1997, 275, 218-220.
110. Delmas, D.; Solary, E.; Latruffe, N. Resveratrol, a phytochemical inducer of multiple cell death pathways: apoptosis, autophagy and mitotic catastrophe. Curr. Med. Chem., 2011, 18(8), 1100-1121.
111. Hasima, N.; Ozpolat, B. Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer. Cell Death Dis., 2014, 5, e1509.
112. Lao, F.; Shang, Y.; Liu, D. Autophagy pathway of raji cell death induced by resveratrol. Chinese J. Biologicals, 2009, 22, 654-658.
113. Lao, C.D.; Demierre, M.F.; Sondak, V.K. Targeting events in melanoma carcinogenesis for the prevention of melanoma. Expert Rev. Anticancer Ther., 2006, 6(11), 1559-1568.
114. Opipari, A.W. Jr; Tan, L.; Boitano, A.E.; Sorenson, D.R.; Aurora, A.; Liu, J.R. Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res., 2004, 64, 696-703.
115. Scarlatti, F.; Maffei, R.; Beau, I.; Ghidoni, R.; Codogno, P. Noncanonical autophagy: an exception or an underestimated form of autophagy? Autophagy, 2008, 4(8), 1083-1085.
116. Scarlatti, F.; Maffei, R.; Beau, I.; Codogno, P.; Ghidoni, R. Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells. Cell Death Differ., 2008, 15, 1318-1329.
117. Puissant, A.; Auberger, P. AMPK-and p62/SQSTM1-dependent autophagy mediate resveratrol-induced cell death in chronic myelogenous leukemia. Autophagy, 2010, 6(5), 655-657.
118. Kumar, B.; Iqbal, M.A.; Singh, R.K.; Bamezai, R.N. Resveratrol inhibits TIGAR to promote ROS induced apoptosis and autophagy. Biochimie, 2015, Jul 23.
119. Lang, F.; Qin, Z.; Li, F.; Zhang, H.; Fang, Z.; Hao, E. Apoptotic Cell Death Induced by Resveratrol Is Partially Mediated by the Autophagy Pathway in Human Ovarian Cancer Cells. PLoS One, 2015, 10(6), e0129196.
120. Selvaraj, S.; Sun, Y.; Sukumaran, P.; Singh, B.B. Resveratrol activates autophagic cell death in prostate cancer cells via downregulation of STIM1 and the mTOR pathway. Mol. Carcinog., 2015, Apr 27.
121. Zhang, J.; Ma, K.; Qi, T.; Wei, X.; Zhang, Q.; Li, G.; Chiu, J.F. P62 regulates resveratrol-mediated Fas/Cav-1 complex formation and transition from autophagy to apoptosis. Oncotarget, 2015, 6(2), 789-801.
122. Fu, Y.; Chang, H.; Peng, X.; Bai, Q.; Yi, L.; Zhou, Y.; Zhu, J.; Mi, M. Resveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/β-catenin signaling pathway. PLoS One, 2014, 9(7), e10253.
123. Ge, J.; Liu, Y.; Li, Q.; Guo, X.; Gu, L.; Ma, Z.G.; Zhu, Y.P. Resveratrol induces apoptosis and autophagy in T-cell acute lym phoblastic leukemia cells by inhibiting Akt/mTOR and activating p38-MAPK. Biomed. Environ. Sci., 2013, 26(11), 902-911.
124. Li, G.; Rivas, P.; Bedolla, R.; Thapa, D.; Reddick, R.L.; Ghosh, R.; Kumar, A.P. Dietary resveratrol prevents development of highgrade prostatic intraepithelial neoplastic lesions: involvement of SIRT1/S6K axis. Cancer Prev. Res. (Philadelphia), 2013, 6(1), 27-39.
125. Zhang, L.; Dai, F.; Sheng, P.L.; Chen, Z.Q.; Xu, Q.P.; Guo, Y.Q. Resveratrol analogue 3,4,4’-trihydroxy-trans-stilbene induces apoptosis and autophagy in human non-small-cell lung cancer cells in vitro. Acta Pharmacol. Sin., 2015, 36(10), 1256-1265.
126. Wang, M.; Yu, T.; Zhu, C.; Sun, H.; Qiu, Y.; Zhu, X.; Li, J. Resveratrol triggers protective through the ceramide/Akt/mTOR pathway in melanoma B16 cells. Nutr. Cancer, 2014, 66(3), 435-440.
127. Siedlecka-Kroplewska, K.; Jozwik, A.; Boguslawski, W.; Wozniak, M.; Zauszkiewicz-Pawlak, A.; Spodnik, J.H.; Rychlowski, M.; Kmiec, Z. Pterostilbene induces accumulation of autophagic vacuoles followed by cell death in HL60 human leukemia cells. J. Physiol. Pharmacol., 2013, 64(5), 545-556.
128. Mena, S.; Rodriguez, M.L.; Ponsoda, X.; Estrela, J.M.; Jaattela, M.; Ortega, A.L. Pterostilbene-induced tumor cytotoxicity: a lysosomal membrane permeabilization-dependent mechanism. PLoS One, 2012, 7(9), e44524
129. Tedesco, I.; Russo, M.; Bilotto, S.; Spagnuolo, C.; Scognamiglio, A.; Palumbo, R.; Nappo, A.; Iacomino, G.; Moio, L.; Russo, G.L. Dealcoholated red wine induces autophagic and apoptotic cell death in an osteosarcoma cell line. Food Chem. Toxicol., 2013, 60, 377-384.
130. Garcia-Zepeda, S.P.; Garcia-Villa, E.; Diaz-Chavez, J.; Hernandez-Pando, R.; Gariglio, P. Resveratrol induces cell death in cervical cancer cells through apoptosis and autophagy. Eur. J. Cancer Prev., 2013, 22(6), 577-584.
131. Miki, H.; Uehara, N.; Kimura, A.; Sasaki, T.; Yuri, T.; Yoshizawa, K.; Tsubura, A. Resveratrol induces apoptosis via ROS-triggered autophagy in human colon cancer cells. Int. J. Oncol., 2012, 40(4), 1020-1028.
132. Yamamoto, M.; Suzuki, S.O.; Himeno, M. Resveratrol-induced autophagy in human U373 glioma cells. Oncol. Lett., 2010, 1(3), 489-493.
133. Siddiqui, I.A.; Malik, A.; Adhami, V.M.; Asim, M.; Hafeez, B.B.; Sarfaraz, S.; Mukhtar, H. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene, 2008, 27, 2055-2063.
134. Tang, S.N.; Singh, C.; Nall, D.; Meeker, D.; Shankar, S.; Srivastava, R.K. The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelialmesenchymal transition. J. Mol. Signal., 2010, 5, 14.
135. Shammas, M.A.; Neri, P.; Koley, H.; Batchu, R.B.; Bertheau, R.C.; Munshi, V.; Prabhala, R.; Fulciniti, M.; Tai, Y.T.; Treon, S.P.; Goyal, R.K.; Anderson, K.C.; Munshi, N.C. Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications. Blood, 2006, 108, 2804-2810.
136. Hu, F.; Wei, F.; Wang, Y.; Wu, B.; Fang, Y.; Xiong, B. EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells. J. Pharmacol. Sci., 2015, 128(1), 27-34.
137. Irimie, A.I.; Braicu, C.; Zanoaga, O.; Pileczki, V.; Gherman, C.; Berindan-Neagoe, I.; Campian, R.S. Epigallocatechin-3-gallate suppresses cell proliferation and promotes apoptosis and autophagy in oral cancer SSC-4 cells. OncoTargets Ther., 2015, 8, 461-470.
138. Zhou, J.; Farah, B.L.; Sinha, R.A.; Wu, Y.; Singh, B.K.; Bay, B.H.; Yang, C.S.; Yen, P.M. Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, stimulates hepatic autophagy and lipid clearance. PLoS One, 2014, 9(1), e87161.
139. Chen, L.; Ye, H.L.; Zhang, G.; Yao, W.M.; Chen, X.Z.; Zhang, F.C.; Liang, G. Autophagy inhibition contributes to the synergistic interaction between EGCG and doxorubicin to kill the hepatoma Hep3B cells. PLoS One, 2014, 9(1), e85771.
140. Satoh, M.; Takemura, Y.; Hamada, H.; Sekido, Y.; Kubota, S. EGCG induces human mesothelioma cell death by inducing reactive oxygen species and autophagy. Cancer Cell Int., 2013, 13(1), 19.
141. Zhang, Y.; Yang, N.D.; Zhou, F.; Shen, T.; Duan, T.; Zhou, J.; Shi, Y.; Zhu, X.Q.; Shen, H.M. (-)-Epigallocatechin-3-gallate induces non-apoptotic cell death in human cancer cells via ROS-mediated lysosomal membrane permeabilization. PLoS One, 2012, 7(10), e46749.
142. Boyanapalli, S.S.; Tony Kong, A.N. "Curcumin, the King of Spices": Epigenetic Regulatory Mechanisms in the Prevention of Cancer, Neurological, and Inflammatory Diseases. Curr. Pharmacol. Rep., 2015, 1(2), 129-139.
143. Aoki, H.; Takada, Y.; Kondo, S.; Sawaya, R.; Aggarwal, B.B.; Kondo, Y. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol. Pharmacol., 2007, 72, 29-39.
144. Jia Y.L.; Li, J.; Qin, Z.H.; Liang Z.Q. Autophagic and apoptotic mechanisms of curcumin-induced death in K562 cells. J. Asian Nat. Prod. Res., 2009, 11, 918-928.
145. Zhou, D.Y.; Ding, N.; Du, Z.Y.; Cui, X.X.; Wang, H.; Wei, X.C.; Conney, A.H.; Zhang, K.; Zheng, X. Curcumin analogues with high activity for inhibiting human prostate cancer cell growth and androgen receptor activation. Mol. Med. Rep., 2014, 10, 1315-1322.
146. Akkoc, Y.; Berrak, O.; Arısan, E.D.; Obakan, P.; Coker-Gurkan, A.; Palavan-Unsal, N. Inhibition of PI3K signaling triggered apoptotic potential of curcumin which is hindered by Bcl-2 through activation of autophagy in MCF-7 cells. Biomed. Pharmacother., 2015, 71, 161-71.
147. Xiao, K.; Jiang, J.; Guan, C.; Dong, C.; Wang, G.; Bai, L.; Sun, J.; Hu, C.; Bai, C. Curcumin induces autophagy via activating the AMPK signaling pathway in lung adenocarcinoma cells. J. Pharmacol. Sci., 2013, 123(2), 102-109.
148. Lee, Y.J.; Kim, N.Y.; Suh, Y.A.; Lee, C. Involvement of ROS in curcumin-induced autophagic cell death. Korean J. Physiol. Pharmacol., 2011, 15, 1-7.
149. Shinojima, N.; Yokoyama, T.; Kondo, Y.; Kondo, S. Roles of the Akt/mTOR/p70S6K and ERK1/2 signaling pathways in curcumininduced autophagy. Autophagy, 2007, 3, 635-637.
150. Qian, H.; Yang, Y.; Wang, X. Curcumin enhanced adriamycininduced human liver-derived Hepatoma G2 cell death through activation of mitochondria-mediated apoptosis and autophagy. Eur. J. Pharm. Sci., 2011, 43(3), 125-131.
151. Thongrakard V, Titone R, Follo C, Morani F, Suksamrarn A, Tencomnao T, Isidoro C Turmeric toxicity in A431 epidermoid cancer cells associates with autophagy degradation of anti-apoptotic and anti-autophagic p53 mutant. Phytother. Res., 2014, 28(12), 1761-1769.
152. Li, B.; Takeda, T.; Tsuiji, K.; Wong, T.F.; Tadakawa, M.; Kondo, A.; Nagase, S.; Yaegashi, N. Curcumin induces cross-regulation between autophagy and apoptosis in uterine leiomyosarcoma cells. Int. J. Gynecol. Cancer, 2013, 23(5), 803-808.
153. Kim, J.Y.; Cho, T.J.; Woo, B.H.; Choi, K.U.; Lee, C.H.; Ryu, M.H.; Park, H.R. Curcumin-induced autophagy contributes to the decreased survival of oral cancer cells. Arch. Oral Biol., 2012, 57(8), 1018-1025.
154. Yamauchi, Y.; Izumi, Y.; Asakura, K.; Hayashi, Y.; Nomori, H. Curcumin induces autophagy in ACC-MESO-1 cells. Phytother. Res., 2012, 26(12), 1779-1783.
155. Zhuang, W.; Long, L.; Zheng, B.; Ji, W.; Yang, N.; Zhang, Q.; Liang, Z. Curcumin promotes differentiation of glioma-initiating cells by inducing autophagy. Cancer Sci., 2012, 103(4), 684-690.
156. Wu, J.C.; Lai, C.S.; Badmaev, V.; Nagabhushanam, K.; Ho, C.T.; Pan, M.H. Tetrahydrocurcumin, a major metabolite of curcumin, induced autophagic cell death through coordinative modulation of PI3K/Akt-mTOR and MAPK signaling pathways in human leukemia HL-60 cells. Mol. Nutr. Food Res., 2011, 55(11), 1646-1654.
157. Wang, N.; Pan, W.; Zhu, M.; Zhang, M.; Hao, X.; Liang, G.; Feng, Y. Fangchinoline induces autophagic cell death via p53/sestrin2/AMPK signalling in human hepatocellular carcinoma cells. Br. J. Pharmacol., 2011, 164(2b), 731-742.
158. Wong, A.S.; Che, C.M.; Leung, K.W. Recent advances in ginseng as cancer therapeutics: a functional and mechanistic overview. Nat. Prod. Rep., 2015, 32(2), 256-272.
159. Choi, J.S.; Chun, K.S.; Kundu, J.; Kundu, J.K. Biochemical basis of cancer chemoprevention and/or chemotherapy with ginsenosides. Int. J. Mol. Med., 2013, 32(6), 1227-1238.
160. Nag, S.A.; Qin, J.J.; Wang, W.; Wang, M.H.; Wang, H.; Zhang, R. Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure-Activity Relationships, and Molecular Mechanisms of Action. Front. Pharmacol., 2012, 3, 25.
161. Chang, Y.S.; Seo, E.K.; Gyllenhaal, C.; Block, K.I. Panax ginseng: a role in cancer therapy? Integr. Cancer Ther., 2003, 2(1), 13-33.
162. Yun, T.K.; Lee, Y.S.; Lee, Y.H.; Kim, S.I.; Yun, H.Y. Anticarcinogenic effect of Panax ginseng C.A. Meyer and identification of active compounds. J. Korean Med. Sci., 2001, 16 (Suppl), S6-18.
163. Kim, S.M.; Lee, S.Y.; Cho, J.S.; Son, S.M.; Choi, S.S.; Yun, Y.P.; Yoo, H.S.; Yoon do Y, Oh, K.W.; Han, S.B.; Hong, J.T. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB. Eur. J. Pharmacol., 2010, 631, 1-9.
164. Kim, D.G.; Jung, K.H.; Lee, D.G.; Yoon, J.H.; Choi, K.S.; Kwon, S.W.; Shen, H.M.; Morgan, M.J.; Hong, S.S.; Kim, Y.S. 20(S)-Ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin. Oncotarget, 2014, 5(12), 4438-4451.
165. Ko, H.; Kim, Y.J.; Park, J.S.; Park, J.H.; Yang, H.O. Autophagy inhibition enhances apoptosis induced by ginsenoside Rk1 in hepatocellular carcinoma cells. Biosci. Biotechnol. Biochem., 2009, 73(10), 2183-2189.
166. Kim, A.D.; Kang, K.A.; Kim, H.S.; Kim, D.H.; Choi, Y.H.; Lee, S.J.; Kim, H.S.; Hyun, J.W. A ginseng metabolite, compound K, induces autophagy and apoptosis via generation of reactive oxygen species and activation of JNK in human colon cancer cells. Cell Death Dis., 2013, 4, e750.
167. Mai, T.T.; Moon, J.; Song, Y.; Viet, P.Q.; Phuc, P.V.; Lee, J.M.; Yi, T.H.; Cho, M.; Cho, S.K. Ginsenoside F2 induces apoptosis accompanied by protective autophagy in breast cancer stem cells. Cancer Lett., 2012, 321, 144-153.
168. Huang, M.; Lu, J.J.; Huang, M.Q.; Bao, J.L.; Chen, X.P.; Wang, Y.T. Terpenoids: natural compounds for cancer therapy. Expert Opin. Investig. Drugs, 2012, 21(12), 1801-1818.
169. Ghantous, A.; Gali-Muhtasib, H.; Vuorela, H.; Saliba, N.A.; Darwiche, N. What made sesquiterpene lactones reach cancer clinical trials? Drug Discov. Today, 2010, 15(15-16), 668-678.
170. Yang, H.; Dou, Q.P. Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer. Curr. Drug Targets, 2010, 11(6), 733-744
171. Merfort, I. Perspectives on sesquiterpene lactones in inflammation and cancer. Curr. Drug Targets, 2011, 12(11), 1560-1573
172. Kreuger, M.R.; Grootjans, S.; Biavatti, M.W.; Vandenabeele, P.; D’Herde, K. Sesquiterpene lactones as drugs with multiple targets in cancer treatment: focus on parthenolide. Anticancer Drugs, 2012, 23(9), 883-896.
173. Ghantous, A.; Sinjab, A.; Herceg, Z.; Darwiche, N. Parthenolide: from plant shoots to cancer roots. Drug Discov. Today, 2013, 18(17-18), 894-905.
174. Schneider-Stock, R.; Ghantous, A.; Bajbouj, K.; Saikali, M.; Darwiche, N. Epigenetic mechanisms of plant-derived anticancer drugs. Front Biosci., 2012, 17, 129-173
175. D’Anneo, A.; Carlisi, D.; Lauricella, M.; Puleio, R.; Martinez, R.; Di Bella, S.; Di Marco, P.; Emanuele, S.; Di Fiore, R.; Guercio, A.; Vento, R.; Tesoriere, G. Parthenolide generates reactive oxygen species and autophagy in MDA-MB231 cells. A soluble parthenolide analogue inhibits tumour growth and metastasis in a xenograft model of breast cancer. Cell Death Disease, 2013, 4, e891.
176. Sun, J.; Zhang, C.; Bao, Y.L.; Wu, Y.; Chen, Z.L.; Yu, C.L.; Huang, Y.X.; Sun, Y.; Zheng, L.H.; Wang, X.; Li, Y.X. Parthenolide-induced apoptosis, autophagy and suppression of proliferation in HepG2 cells. Asian Pac. J. Cancer Prev., 2014, 15(12), 4897-4902
177. Lan, B.; Wan, Y.J.; Pan, S.; Wang, Y.; Yang, Y.; Leng, Q.L.; Jia, H.; Liu, Y.H.; Zhang, C.Z.; Cao, Y. Parthenolide induces autophagy via the depletion of 4E-BP1. Biochem. Biophys. Res. Commun., 2015, 456(1), 434-439.
178. Li, X.J.; Jiang, Z.Z.; Zhang, L.Y. Triptolide: progress on research in pharmacodynamics and toxicology. J. Ethnopharmacol., 2014, 155(1), 67-79.
179. Chen, L.; Liu, Q.; Huang, Z.; Wu, F.; Li, Z.; Chen, X.; Lin, T. Tripchlorolide induces cell death in lung cancer cells by autophagy. Int. J. Oncol., 2012, 40(4), 1066-1070.
180. Yang, S.; Chen, J.; Guo, Z.; Xu, X.M.; Wang, L.; Pei, X.F.; Yang, J.; Underhill, C.B.; Zhang, L. Triptolide inhibits the growth and metastasis of solid tumors. Mol. Cancer Ther., 2003, 2(1), 65-72
181. Mujumdar, N.; Mackenzie, T.N.; Dudeja, V.; Chugh, R.; Antonoff, M.B.; Borja-Cacho, D.; Sangwan, V.; Dawra, R.; Vickers, S.M.; Saluja, A.K. Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways. Gastroenterology, 2010, 139(2), 598-608.
182. Mujumdar, N.; Banerjee, S.; Chen, Z.; Sangwan, V.; Chugh, R.; Dudeja, V.; Yamamoto, M.; Vickers, S.M.; Saluja, A.K. Triptolide activates unfolded protein response leading to chronic ER stress in pancreatic cancer cells. Am. J. Physiol. Gastrointest. Liver Physiol., 2014, 306(11), G1011-1020.
183. Krosch, T.C.; Sangwan, V.; Banerjee, S.; Mujumdar, N.; Dudeja, V.; Saluja, A.K.; Vickers, S.M. Triptolide-mediated cell death in neuroblastoma occurs by both apoptosis and autophagy pathways and results in inhibition of nuclear factor-kappa B activity. Am. J. Surg., 2013, 205(4), 387-396.
184. Fulda, S. Betulinic acid for cancer treatment and prevention. Int. J. Mol. Sci., 2008, 9(6), 1096-1107.
185. Gheorgheosu, D.; Duicu, O.; Dehelean, C.; Soica, C.; Muntean, D. Betulinic acid as a potent and complex antitumor phytochemical: a minireview. AntiCancer Agents Med. Chem., 2014, 14(7), 936-945.
186. Gonzalez, P.; Mader, I.; Tchoghandjian, A.; Enzenmuller, S.; Cristofanon, S.; Basit, F.; Debatin, K.M.; Fulda, S. Impairment of lysosomal integrity by B10, a glycosylated derivative of betulinic acid, leads to lysosomal cell death and converts autophagy into a detrimental process. Cell Death Differ., 2012, 19(8), 1337-1346.
187. Yang, L.J.; Chen, Y.; He, J.; Yi, S.; Wen, L.; Zhao, J.; Zhang, B.P.; Cui, G.H. Betulinic acid inhibits autophagic flux and induces apoptosis in human multiple myeloma cells in vitro. Acta Pharmacol. Sin., 2012, 33(12), 1542-1548.
188. Potze, L.; Mullauer, F.B.; Colak, S.; Kessler, J.H.; Medema, J.P. Betulinic acid-induced mitochondria-dependent cell death is counterbalanced by an autophagic salvage response. Cell Death Dis., 2014, 5, e1169.
189. Cui, Q.; Tashiro, S.; Onodera, S.; Ikejima, T. Augmentation of oridonin-induced apoptosis observed with reduced autophagy. J. Pharmacol. Sci., 2006, 101(3), 230-239.
190. Ye, Y.C.; Wang, H.J.; Xu, L.; Liu, W.W.; Liu, B.B.; Tashiro, S.; Onodera, S.; Ikejima, T. Oridonin induces apoptosis and autophagy in murine fibrosarcoma L929 cells partly via NO-ERK-p53 positive-feedback loop signaling pathway. Acta Pharmacol. Sin., 2012, 33(8), 1055-1061.
191. Cheng, Y.; Qiu, F.; Ikejima, T. Molecular mechanisms of oridonininduced apoptosis and autophagy in murine fibrosarcoma L929 cells. Autophagy, 2009, 5(3), 430-431.
192. Cheng, Y.; Qiu, F.; Ye, Y.C.; Guo, Z.M.; Tashiro, S.; Onodera, S.; Ikejima, T. Autophagy inhibits reactive oxygen species-mediated apoptosis via activating p38-nuclear factor-kappa B survival pathways in oridonin-treated murine fibrosarcoma L929 cells. FEBS J., 2009, 276(5), 1291-1306.
193. Cheng, Y.; Qiu, F.; Huang, J.; Tashiro, S.; Onodera, S.; Ikejima, T. Apoptosis-suppressing and autophagy-promoting effects of calpain on oridonin-induced L929 cell death. Arch. Biochem. Biophys., 2008, 475(2), 148-55.
194. Banjerdpongchai, R.; Khaw-On, P. Terpinen-4-ol induces autophagic and apoptotic cell death in human leukemic HL-60 cells. Asian Pac. J. Cancer Prev., 2013, 14(12), 7537-7542.
195. Yang, H.; Chen, D.; Cui, Q.C.; Yuan, X.; Dou, Q.P. Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res., 2006, 66(9), 4758-4765.
196. Guo, J.; Huang, X.; Wang, H.; Yang, H. Celastrol Induces Autophagy by Targeting AR/miR-101 in Prostate Cancer Cells. PLoS One, 2015, 10(10), e0140745.
197. Li, H.Y.; Zhang, J.; Sun, L.L.; Li, B.H.; Gao, H.L.; Xie, T.; Zhang, N.; Ye, Z.M. Celastrol induces apoptosis and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells: an in vitro and in vivo study. Cell Death Dis., 2015, 6, e1604.
198. Han, X.; Sun, S.; Zhao, M.; Cheng, X.; Chen, G.; Lin, S.; Guan, Y.; Yu, X. Celastrol stimulates hypoxia-inducible factor-1 activity in tumor cells by initiating the ROS/Akt/p70S6K signaling pathway and enhancing hypoxia-inducible factor-1α protein synthesis. PLoS One, 2014, 9(11), e112470.
199. Ma, J.; Han, L.Z.; Liang, H.; Mi, C.; Shi, H.; Lee, J.J.; Jin, X. Celastrol inhibits the HIF-1α pathway by inhibition of mTOR/p70S6K/eIF4E and ERK1/2 phosphorylation in human hepatoma cells. Oncol. Rep., 2014, 32(1), 235-242.
200. Boridy, S.; Le, P.U.; Petrecca, K.; Maysinger, D. Celastrol targets proteostasis and acts synergistically with a heat-shock protein 90 inhibitor to kill human glioblastoma cells. Cell Death Dis., 2014, 5, e1216.
201. Lee, H.W.; Jang, K.S.; Choi, H.J.; Jo, A.; Cheong, J.H.; Chun, K.H. Celastrol inhibits gastric cancer growth by induction of apoptosis and autophagy. BMB Rep., 2014, 47(12), 697-702.
202. Wang, W.B.; Feng, L.X.; Yue, Q.X.; Wu, W.Y.; Guan, S.H.; Jiang, B.H.; Yang, M.; Liu, X.; Guo, D.A. Paraptosis accompanied by autophagy and apoptosis was induced by celastrol, a natural compound with influence on proteasome, ER stress and Hsp90. J. Cell. Physiol., 2012, 227(5), 2196-2206.
203. Fahey, J.W.; Talalay, P. Antioxidant functions of sulforaphane: a potent inducer of phase II detoxication enzymes. Food Chem. Toxicol., 1999, 37(9-10), 973-979.
204. Herman-Antosiewicz, A.; Johnson, D.E.; Singh, S.V. Sulforaphane causes autophagy to inhibit release of cytochrome C and apoptosis in human prostate cancer cells. Cancer Res., 2006, 66(11), 5828-5835.
205. Jackson, S.J.; Singletary, K.W. Sulforaphane inhibits human MCF-7 mammary cancer cell mitotic progression and tubulin polymerization. J. Nutr., 2004, 134(9), 2229-2236.
206. Azarenko O.; Okouneva, T.; Singletary, K.W.; Jordan, M.A.; Wilson, L. Suppression of microtubule dynamic instability and turnover in MCF7 breast cancer cells by sulforaphane. Carcinogenesis, 2008, 29(12), 2360-2368.
207. Mi, L.; Xiao, Z.; Hood, B.L.; Dakshanamurthy, S.; Wang, X.; Govind, S.; Conrads, T.P.; Veenstra, T.D.; Chung, F.L. Covalent binding to tubulin by isothiocyanates. A mechanism of cell growth arrest and apoptosis. J. Biol. Chem., 2008, 283(32), 22136-22146.
208. Parnaud, G.; Li, P.; Cassar, G.; Rouimi, P.; Tulliez, J.; Combaret, L.; Gamet-Payrastre, L. Mechanism of sulforaphane-induced cell cycle arrest and apoptosis in human colon cancer cells. Nutr. Cancer, 2004, 48(2), 198-206.
209. Pawlik, A.; Wiczk, A.; Kaczynska, A.; Antosiewicz, J.; Herman-Antosiewicz, A. Sulforaphane inhibits growth of phenotypically different breast cancer cells. Eur. J. Nutr., 2013, 52(8), 1949-1958.
210. Arthur, C.R.; Gupton, J.T.; Kellogg, G.E.; Yeudall, W.A.; Cabot, M.C.; Newsham, I.F.; Gewirtz, D.A. Autophagic cell death, polyploidy and senescence induced in breast tumor cells by the substituted pyrrole JG-03-14, a novel microtubule poison. Biochem. Pharmacol., 2007, 74(7), 981-991.
211. Biggers, J.W.; Nguyen, T.; Di, X.; Gupton, J.T.; Henderson, S.C.; Emery, S.M.; Alotaibi, M.; White, K.L. Jr; Brown, R.; Almenara, J.; Gewirtz, D.A. Autophagy, cell death and sustained senescence arrest in B16/F10 melanoma cells and HCT-116 colon carcinoma cells in response to the novel microtubule poison, JG-03-14. Cancer Chemother. Pharmacol., 2013, 71(2), 441-455.
212. Larocque, K.; Ovadje, P.; Djurdjevic, S.; Mehdi, M.; Green, J.; Pandey, S. Novel analogue of colchicine induces selective prodeath autophagy and necrosis in human cancer cells. PLoS One, 2014, 9(1), e87064.
213. Amagase, H. Clarifying the real bioactive constituents of garlic. J Nutr., 2006, 136, 716-725.
214. Altonsy, M.O.; Andrews, S.C. Diallyl disulphide, a beneficial component of garlic oil, causes a redistribution of cell-cycle growth phases, induces apoptosis, and enhances butyrate-induced apoptosis in colorectal adenocarcinoma cells (HT-29). Nutr. Cancer, 2011, 63, 1104-1113.
215. Chu, Y.L.; Ho, C.T.; Chung, J.G.; Rajasekaran, R.; Sheen, L.Y. Allicin induces p53-mediated autophagy in Hep G2 human liver cancer cells. J. Agric. Food Chem., 2012, 60, 8363-8371.
216. Chu, Y.L.; Ho, C.T.; Chung, J.G.; Raghu, R.; Lo, Y.C.; Sheen, L.Y. Allicin induces anti-human liver cancer cells through the p53 gene modulating apoptosis and autophagy. J. Agric. Food Chem., 2013, 61(41), 9839-9848.
217. Wang, Y.; Liu, Y.; Liu, X.; Jiang, L.; Yang, G.; Sun, X.; Geng, C.; Li, Q.; Yao, X.; Chen, M. Citreoviridin Induces Autophagy-Dependent Apoptosis through Lysosomal-Mitochondrial Axis in Human Liver HepG2 Cells. Toxins (Basel), 2015, 7(8), 3030-3044.
218. Liu, Y.N.; Wang, Y.X.; Liu, X.F.; Jiang, L.P.; Yang, G.; Sun, X.C.; Geng, C.Y.; Li, Q.J.; Chen, M.; Yao, X.F. Citreoviridin induces ROS-dependent autophagic cell death in human liver HepG2 cells. Toxicon, 2015, 95, 30-37.
219. Wu, P.F.; Chiu, C.C.; Chen, C.Y.; Wang, H.D. 7-Hydroxydehydronuciferine induces human melanoma death via triggering autophagy and apoptosis. Exp. Dermatol., 2015, Jul 14.
220. Dyshlovoy, S.A.; Hauschild, J.; Amann, K.; Tabakmakher, K.M.; Venz, S.; Walther, R.; Guzii, A.G.; Makarieva, T.N.; Shubina, L.K.; Fedorov, S.N.; Stonik, V.A.; Bokemeyer, C.; Balabanov, S.; Honecker, F.; von Amsberg, G. Marine alkaloid Monanchocidin a overcomes drug resistance by induction of autophagy and lysosomal membrane permeabilization. Oncotarget, 2015, 6(19), 17328-17341.
221. Hu, T.; Wang, L.; Zhang, L.; Lu, L.; Shen, J.; Chan, R.L.; Li, M.; Wu, W.K.; To, K.K.; Cho, C.H. Sensitivity of apoptosis-resistant colon cancer cells to tanshinones is mediated by autophagic cell death and p53-independent cytotoxicity. Phytomedicine, 2015, 22(5), 536-544.
222. Kim, Y.J.; Kang, K.S.; Choi, K.C.; Ko, H. Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells. Bioorg. Med. Chem. Lett., 2015, 25(12), 2559-2564.
223. Lyu, Q.; Tou, F.; Su, H.; Wu, X.; Chen, X.; Zheng, Z. The natural product peiminine represses colorectal carcinoma tumor growth by inducing autophagic cell death. Biochem. Biophys. Res. Commun., 2015, 462(1), 38-45.
224. Armstrong, J.L.; Hill, D.S.; McKee, C.S.; Hernandez-Tiedra, S.; Lorente, M.; Lopez-Valero, I.; Eleni Anagnostou, M.; Babatunde, F.; Corazzari, M.; Redfern, C.P.; Velasco, G.; Lovat, P.E. Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death. J. Invest. Dermatol., 2015, 135(6), 1629-1637.
225. Ramirez-Orellana, M.I.; Velazquez, G.; Lorente, M.; Ratovitski, E.A. Cytotoxic evaluation of the action of naturally derived compounds on glioma cells. Abstracts of the Keystone Symposia of Molecular and Cell Biology. October 28-November 2, 2014, San Paulo, Brazil, Abstract 3050, p. 86.
226. Tang, Z.H.; Li, T.; Chang, L.L.; Zhu, H.; Tong, Y.G.; Chen, X.P.; Wang, Y.T.; Lu, J.J. Glycyrrhetinic Acid triggers a protective autophagy by activation of extracellular regulated protein kinases in hepatocellular carcinoma cells. J. Agric. Food Chem., 2014, 62(49), 11910-11916.
227. Shi, L.; Zhang, T.; Zhou, Y.; Zeng, X.; Ran, L.; Zhang, Q.; Zhu, J.; Mi, M. Dihydromyricetin improves skeletal muscle insulin sensitivity by inducing autophagy via the AMPK-PGC-1α-Sirt3 signaling pathway. Endocrine, 2015, Apr 21.
228. Chiu, C.T.; Hsuan, S.W.; Lin, H.H.; Hsu, C.C.; Chou, F.P.; Chen, J.H. Hibiscus sabdariffa leaf polyphenolic extract induces human melanoma cell death, apoptosis, and autophagy. J. Food Sci., 2015, 80(3), H649-658.
229. Su, C.C. Sann-Joong-Kuey-Jian-Tang decreases the protein expression of mammalian target of rapamycin but increases microtubule associated protein II light chain 3 expression to inhibit human BxPC_3 pancreatic carcinoma cells. Mol. Med. Rep., 2015, 11(4), 3160-3166.
230. Trzoss, L.; Fukuda, T.; Costa-Lotufo, L.V.; Jimenez, P.; La Clair, J.J.; Fenical, W. Seriniquinone, a selective anticancer agent, induces cell death by autophagocytosis, targeting the cancerprotective protein dermcidin. Proc. Natl. Acad. Sci. U. S. A., 2014, 111(41), 14687-14692.
231. Juncker, T.; Schumacher, M.; Dicato, M.; Diederich, M. UNBS1450 from Calotropis procera as a regulator of signaling pathways involved in proliferation and cell death. Biochem. Pharmacol., 2009, 78(1), 1-10.
232. Xu, D.; Lao, Y.; Xu, N.; Hu, H.; Fu, W.; Tan, H.; Gu, Y.; Song, Z.; Cao, P.; Xu, H. Identification and characterization of anticancer compounds targeting apoptosis and autophagy from Chinese native Garcinia species. Planta Med., 2015, 81(1), 79-89.
233. Feng, C.; Zhou, L.Y.; Yu, T.; Xu, G.; Tian, H.L.; Xu, J.J.; Xu, H.X.; Luo, K.Q. A new anticancer compound, oblongifolin C, inhibits tumor growth and promotes apoptosis in HeLa cells through Bax activation. Int. J. Cancer, 2012, 131(6), 1445-1454.
234. Lao, Y.; Wan, G.; Liu, Z.; Wang, X.; Ruan, P.; Xu, W.; Xu, D.; Xie, W.; Zhang, Y.; Xu, H.; Xu, N. The natural compound oblongifolin C inhibits autophagic flux and enhances antitumor efficacy of nutrient deprivation. Autophagy, 2014, 10(5), 736-749.
235. Wang, X.; Lao, Y.; Xu, N.; Xi, Z.; Wu, M.; Wang, H.; Li, X.; Tan, H.; Sun, M.; Xu, H. Oblongifolin C inhibits metastasis by upregulating keratin 18 and tubulins. Sci. Rep., 2015, 5, 10293.
236. Ouyang, L.; Chen, Y.; Wang, X.Y.; Lu, R.F.; Zhang, S.Y.; Tian, M.; Xie, T.; Liu, B.; He, G. Polygonatum odoratum lectin induces apoptosis and autophagy via targeting EGFR-mediated Ras-Raf MEK-ERK pathway in human MCF-7 breast cancer cells. Phytomedicine, 2014, 21(12), 1658-1665.
237. Li, C.; Chen, J.; Lu, B.; Shi, Z.; Wang, H.; Zhang, B.; Zhao, K.; Qi, W.; Bao, J.; Wang, Y. Molecular switch role of Akt in Polygonatum odoratum lectin-induced apoptosis and autophagy in human non-small cell lung cancer A549 cells. PLoS One, 2014, 9(7), e101526.
238. Wang, S.Y.; Yu, Q.J.; Bao, J.K.; Liu, B. Polygonatum cyrtonema lectin, a potential antineoplastic drug targeting programmed cell death pathways. Biochem. Biophys. Res. Commun., 2011, 406(4), 497-500.
239. Liu, B.; Cheng, Y.; Bian, H.J.; Bao, J.K. Molecular mechanisms of Polygonatum cyrtonema lectin-induced apoptosis and autophagy in cancer cells. Autophagy, 2009, 5(2), 253-255.
240. Liu, B.; Cheng, Y.; Zhang, B.; Bian, H.J.; Bao, J.K. Polygonatum cyrtonema lectin induces apoptosis and autophagy in human melanoma A375 cells through a mitochondria-mediated ROS-p38-p53 pathway. Cancer Lett., 2009, 275(1), 54-60.
241. Carvalho, F.C.; Soares, S.G.; Tamarozzi, M.B.; Rego, E.M.; Roque-Barreira, M.C. The recognition of N-glycans by the lectin ArtinM mediates cell death of a human myeloid leukemia cell line. PLoS One, 2011, 6(11), e27892.
242. Zhang, C.Z.; Fang, E.F.; Zhang, H.T.; Liu, L.L.; Yun, J.P. Momordica charantia lectin exhibits antitumor activity towards hepatocellular carcinoma. Invest. New Drugs, 2015, 33(1), 1-11.
243. Pratt, J.; Annabim B. Induction of autophagy biomarker BNIP3 requires a JAK2/STAT3 and MT1-MMP signaling interplay in Concanavalin-A-activated U87 glioblastoma cells. Cell Signal., 2014, 26(5), 917-924.
244. Chen, M.C.; Lee, N.H.; Hsu, H.H.; Ho, T.J.; Tu, C.C.; Hsieh, D.J.; Lin, Y.M.; Chen, L.M.; Kuo, W.W.; Huang, C.Y. Thymoquinone induces caspase-independent, autophagic cell death in CPT-11-resistant lovo colon cancer via mitochondrial dysfunction and activation of JNK and p38. J. Agric. Food Chem., 2015, 63(5), 1540-1546.
245. Hahm, E.R.; Sakao, K.; Singh, S.V. Honokiol activates reactive oxygen species-mediated cytoprotective autophagy in human prostate cancer cells. Prostate, 2014, 74(12), 1209-1221.
246. Zhang, L.; Wang, H.; Zhu, J.; Xu, J.; Ding, K. Mollugin induces tumor cell apoptosis and autophagy via the PI3K/AKT/mTOR/p70S6K and ERK signaling pathways. Biochem. Biophys. Res. Commun., 2014, 450(1), 247-254.
247. Lu, J.; Sun, D.; Gao, S.; Gao, Y.; Ye, J.; Liu, P. Cyclovirobuxine D induces autophagy-associated cell death via the Akt/mTOR pathway in MCF-7 human breast cancer cells. J. Pharmacol. Sci., 2014, 125(1), 74-82.
248. Xu, M.Y.; Lee, S.Y.; Kang, S.S.; Kim, Y.S. Antitumor activity of jujuboside B and the underlying mechanism via induction of apoptosis and autophagy. J. Nat. Prod., 2014, 77(2), 370-376.
249. Kaewpiboon, C.; Surapinit, S.; Malilas, W.; Moon, J.; Phuwapraisirisan, P.; Tip-Pyang, S.; Johnston, R.N.; Koh, S.S.; Assavalapsakul, W.; Chung, Y.H. Feroniellin A-induced autophagy causes apoptosis in multidrug-resistant human A549 lung cancer cells. Int. J. Oncol., 2014, 44(4), 1233-1242.
250. Fulda, S. The mechanism of necroptosis in normal and cancer cells. Cancer Biol. Ther., 2013, 14(11), 999-1004.
251. Li, J.; Yin, Q.; Wu, H. Structural basis of signal transduction in the TNF receptor superfamily. Adv. Immunol., 2013, 119, 135-153.
252. Vanden Berghe, T; Linkermann, A; Jouan-Lanhouet, S; Walczak, H; Vandenabeele, P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat. Rev. Mol. Cell. Biol., 2014, 15 (2): 135-47.
253. Newton, K. RIPK1 and RIPK3: critical regulators of inflammation and cell death. Trends Cell Biol., 2015, 25(6), 347-353.
254. Galluzzi, L.; Kepp, O.; Krautwald, S.; Kroemer, G.; Linkermann, A. Molecular mechanisms of regulated necrosis. Semin. Cell Dev. Biol., 2014, 35, 24-32.
255. Wallach, D.; Kang, T.B.; Yang, S.H.; Kovalenko, A. The in vivo significance of necroptosis: lessons from exploration of caspase-8 function. Cytokine Growth Factor Rev., 2014, 25(2), 157-165.
256. Christofferson, D.E.; Li, Y.; Yuan, J. Control of life-or-death decisions by RIP1 kinase. Annu. Rev. Physiol., 2014, 76, 129-150.
257. Moriwaki, K.; Chan, F.K. RIP3: a molecular switch for necrosis and inflammation. Genes Dev., 2013, 27(15), 1640-1649.
258. Nikoletopoulou, V.; Markaki, M.; Palikaras, K.; Tavernarakis, N. Crosstalk between apoptosis, necrosis and autophagy. Biochim. Biophys. Acta, 2013, 1833(12), 3448-3459.
259. Mathis, B.J.; Lai, Y.; Qu, C.; Janicki, J.S.; Cui, T. CYLD-mediated signaling and diseases. Curr. Drug Targets, 2015, 16(4), 284-294.
260. Zhou, W.; Yuan, J. Necroptosis in health and diseases. Semin. Cell Dev. Biol., 2014, 35, 14-23.
261. Danappel, M.; Vlantis, K.; Kumari, S.; Polykratis, A.; Kim, C.; Wachsmuth, L.; Eftychi, C.; Lin, J.; Corona, T.; Hermance, N.; Zelic, M.; Kirsch, P.; Basic, M.; Bleich, A.; Kelliher, M.; Pasparakis, M. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature, 2014, 513(7516), 90-94.
262. Wang, H; Sun, L; Su, L; Rizo, J; Liu, L; Wang, LF; Wang, FS; Wang, X. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol. Cell, 2014, 54 (1): 133-146.
263. Galluzzi, L.; Kepp, O.; Kroemer, G. MLKL regulates necrotic plasma membrane permeabilization. Cell Res., 2014, 24(2), 139-140.
264. Cai, Z.; Jitkaew, S.; Zhao, J.; Chiang, H.C.; Choksi, S.; Liu, J.; Ward, Y.; Wu, L.G.; Liu, Z.G. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat. Cell Biol., 2014, 16(1), 55-65.
265. Kaczmarek, A.; Vandenabeele, P.; Krysko, D.V. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity, 2013, 38 (2), 209-223.
266. Krysko, D.V.; Agostinis, P.; Krysko, O.; Garg, A.D.; Bachert, C.; Lambrecht, B.N.; Vandenabeele, P. Emerging role of damageassociated molecular patterns derived from mitochondria in inflammation. Trends Immunol. 2011, 32 (4), 157-164.
267. Lotze, M.T.; Deisseroth, A.; Rubartelli, A. Damage associated molecular pattern molecules. Clin. Immunol., 2007, 124 (1), 1-4.
268. Han, W.; Xie, J.; Li, L.; Liu, Z.; Hu, X. Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis. Apoptosis, 2009, 14(5), 674-686.
269. Piacentini, M.; Kroemer, G. Dying to survive-apoptosis, necroptosis, autophagy as supreme experiments of nature. Int. J. Dev. Biol., 2015, 59(1-3), 5-9.
270. Dashzeveg, N.; Yoshida, K. Cell death decision by p53 via control of the mitochondrial membrane. Cancer Lett., 2015, 367(2), 108-112.
271. Jia, L.T.; Zhang, R.; Shen, L.; Yang, A.G. Regulators of carcinogenesis: emerging roles beyond their primary functions. Cancer Lett., 2015, 357(1), 75-82.
272. Zamaraev, A.V.; Kopeina, G.S.; Zhivotovsky, B.; Lavrik, I.N. Cell death controlling complexes and their potential therapeutic role. Cell Mol. Life Sci., 2015, 72(3), 505-517.
273. Huang, Y.; Wu, J.Z.; Li, J.Y.; Xu, W. Know the enemy as well as the weapons in hand: the aberrant death pathways and therapeutic agents in chronic lymphocytic leukemia. Am. J. Cancer Res., 2015, 5(8), 2361-2375.
274. Liu, P.; Xu, B.; Shen, W.; Zhu, H.; Wu, W.; Fu, Y.; Chen, H.; Dong, H.; Zhu, Y.; Miao, K.; Xu, W.; Li, J. Dysregulation of TNFα-induced necroptotic signaling in chronic lymphocytic leukemia: suppression of CYLD gene by LEF1. Leukemia, 2012, 26(6), 1293-1300.
275. Zhang, M.; Harashima, N.; Moritani, T.; Huang, W.; Harada, M. The Roles of ROS and Caspases in TRAIL-Induced Apoptosis and Necroptosis in Human Pancreatic Cancer Cells. PLoS One, 2015, 10(5), e0127386.
276. Schmidt, S.V.; Seibert, S.; Walch-Ruckheim, B.; Vicinus, B.; Kamionka, E.M.; Pahne-Zeppenfeld, J.; Solomayer, E.F.; Kim, Y.J.; Bohle, R.M.; Smola, S. RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activation. Oncotarget, 2015, 6(11), 8635-8647.
277. Melo-Lima, S.; Lopes, M.C.; Mollinedo, F. ERK1/2 acts as a switch between necrotic and apoptotic cell death in ether phospholipid edelfosine-treated glioblastoma cells. Pharmacol. Res., 2015, 95-96, 2-11.
278. Melo-Lima, S.; Celeste Lopes, M.; Mollinedo, F. Necroptosis is associated with low procaspase-8 and active RIPK1 and-3 in human glioma cells. Oncoscience, 2014, 1(10), 649-664.
279. Chen, G.; Cheng, X.; Zhao, M.; Lin, S.; Lu, J.; Kang, J.; Yu, X. RIP1-dependent Bid cleavage mediates TNFα-induced but Caspase-3-independent cell death in L929 fibroblastoma cells. Apoptosis, 2015, 20(1), 92-109.
280. Nugues, A.L.; El Bouazzati, H.; Hetuin, D.; Berthon, C.; Loyens, A.; Bertrand, E.; Jouy, N.; Idziorek, T.; Quesnel, B. RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavage. Cell Death Dis., 2014, 5, e1384.
281. Nomura, M.; Ueno, A.; Saga, K.; Fukuzawa, M.; Kaneda, Y. Accumulation of cytosolic calcium induces necroptotic cell death in human neuroblastoma. Cancer Res., 2014, 74(4), 1056-1066.
282. Fu, Z.; Deng, B.; Liao, Y.; Shan, L.; Yin, F.; Wang, Z.; Zeng, H.; Zuo, D.; Hua, Y.; Cai, Z. The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis. BMC Cancer, 2013, 13, 580.
283. Piao, J.L.; Cui, Z.G.; Furusawa, Y.; Ahmed, K.; Rehman, M.U.; Tabuchi, Y.; Kadowaki, M.; Kondo, T. The molecular mechanisms and gene expression profiling for shikonin-induced apoptotic and necroptotic cell death in U937 cells. Chem. Biol. Interact., 2013, 205(2), 119-127.
284. Deng, B.; Qiu, B. Shikonin inhibits invasiveness of osteosarcoma through MMP13 suppression. Tumour Biol., 2015, Jun 24.
285. Zhao, Q.; Kretschmer, N.; Bauer, R.; Efferth, T. Shikonin and its derivatives inhibit the epidermal growth factor receptor signaling and synergistically kill glioblastoma cells in combination with erlotinib. Int. J. Cancer, 2015, 137(6), 1446-1456.
286. Wada, N.; Kawano, Y.; Fujiwara, S.; Kikukawa, Y.; Okuno, Y.; Tasaki, M.; Ueda, M.; Ando, Y.; Yoshinaga, K.; Ri, M.; Iida, S.; Nakashima, T.; Shiotsu, Y.; Mitsuya, H.; Hata, H. Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells. Int. J. Oncol., 2015, 46(3), 963-972.
287. Huang, C.; Luo, Y.; Zhao, J.; Yang, F.; Zhao, H.; Fan, W.; Ge, P. Shikonin kills glioma cells through necroptosis mediated by RIP-1. PLoS One, 2013, 8(6), e66326.
288. Han, W.; Xie, J.; Fang, Y.; Wang, Z.; Pan, H. Nec-1 enhances shikonin-induced apoptosis in leukemia cells by inhibition of RIP-1 and ERK1/2. Int. J. Mol. Sci., 2012, 13(6), 7212-7225.
289. Xuan, Y.; Hu, X. Naturally-occurring shikonin analogues-a class of necroptotic inducers that circumvent cancer drug resistance. Cancer Lett., 2009, 274(2), 233-242.
290. Hu, X.; Han, W.; Li, L. Targeting the weak point of cancer by induction of necroptosis. Autophagy, 2007, 3(5), 490-492.
291. Han, W.; Li, L.; Qiu, S.; Lu, Q.; Pan, Q.; Gu, Y.; Luo, J.; Hu, X. Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Mol. Cancer Ther., 2007, 6(5), 1641-1649.
292. Jang, S.Y.; Lee, J.K.; Jang, E.H.; Jeong, S.Y.; Kim, J.H. Shikonin blocks migration and invasion of human breast cancer cells through inhibition of matrix metalloproteinase-9 activation. Oncol. Rep., 2014, 31(6), 2827-2833.
293. Li, W.; Liu, J.; Jackson, K.; Shi, R.; Zhao, Y. Sensitizing the therapeutic efficacy of taxol with shikonin in human breast cancer cells. PLoS One, 2014, 9(4), e94079.
294. Yao, Y.; Zhou, Q. A novel antiestrogen agent Shikonin inhibits estrogen-dependent gene transcription in human breast cancer cells. Breast Cancer Res. Treat., 2010, 121(1), 233-240.
295. Hou, Y.; Guo, T.; Wu, C.; He, X.; Zhao, M. Effect of shikonin on human breast cancer cells proliferation and apoptosis in vitro. Yakugaku Zasshi., 2006, 126(12), 1383-1386.
296. Dunai, Z.A.; Imre, G.; Barna, G.; Korcsmaros, T.; Petak, I.; Bauer, P.I.; Mihalik, R. Staurosporine induces necroptotic cell death under caspase-compromised conditions in U937 cells. PLoS One, 2012, 7(7), e41945.
297. Aredia, F.; Scovassi, A.I. Poly(ADP-ribose): a signaling molecule in different paradigms of cell death. Biochem. Pharmacol., 2014, 92(1), 157-163.
298. Sosna, J.; Voigt, S.; Mathieu, S.; Lange, A.; Thon, L.; Davarnia, P.; Herdegen, T.; Linkermann, A.; Rittger, A.; Chan, F.K.; Kabelitz, D.; Schutze, S.; Adam, D. TNF-induced necroptosis and PARP-1-mediated necrosis represent distinct routes to programmed necrotic cell death. Cell Mol. Life Sci., 2014, 71(2), 331-348.
299. Basit, F.; Cristofanon, S.; Fulda, S. Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on autophagosomal membranes. Cell Death Differ., 2013, 20(9), 1161-1173.
300. Urtishak, K.A.; Edwards, A.Y.; Wang, L.S.; Hudome, A.; Robinson, B.W.; Barrett, J.S.; Cao, K.; Cory, L.; Moore, J.S.; Bantly, A.D.; Yu, Q.C.; Chen, I.M.; Atlas, S.R.; Willman, C.L.; Kundu, M.; Carroll, A.J.; Heerema, N.A.; Devidas, M.; Hilden, J.M.; Dreyer, Z.E.; Hunger, S.P.; Reaman, G.H.; Felix, C.A. Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia. Blood, 2013, 121(14), 2689-2703.
301. Bonapace, L.; Bornhauser, B.C.; Schmitz, M.; Cario, G.; Ziegler, U.; Niggli, F.K.; Schafer, B.W.; Schrappe, M.; Stanulla, M.; Bourquin, J.P. Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance. J. Clin. Invest., 2010, 120(4), 1310-1323.
302. Coupienne, I.; Bontems, S.; Dewaele, M.; Rubio, N.; Habraken, Y.; Fulda, S.; Agostinis, P.; Piette, J. NF-kappaB inhibition improves the sensitivity of human glioblastoma cells to 5-aminolevulinic acid-based photodynamic therapy. Biochem. Pharmacol., 2011, 81(5), 606-616.
303. Mohler, H.; Pfirrmann, R.W.; Frei, K. Redox-directed cancer therapeutics: Taurolidine and Piperlongumine as broadly effective antineoplastic agents. Int. J. Oncol., 2014, 45(4), 1329-1336.
304. Han, B.; Wang, T.D.; Shen, S.M.; Yu, Y.; Mao, C.; Yao, Z.J.; Wang, L.S. Annonaceous acetogenin mimic AA005 induces cancer cell death via apoptosis inducing factor through a caspase-3-independent mechanism. BMC Cancer, 2015, 15, 139.
305. Longato, G.B.; Fiorito, G.F.; Vendramini-Costa, D.B.; de Oliveira Sousa, I.M.; Tinti, S.V.; Ruiz, A.L.; de Almeida, S.M.; Padilha, R.J.; Foglio, M.A.; de Carvalho, J.E. Different cell death responses induced by eupomatenoid-5 in MCF-7 and 786-0 tumor cell lines. Toxicol. In Vitro, 2015, 29(5), 1026-1033.
306. Lin, W.; Tongyi, S. Role of Bax/Bcl-2 family members in green tea polyphenol induced necroptosis of p53-deficient Hep3B cells. Tumour Biol., 2014, 35(8), 8065-8075.
307. Pozarowski, P.; Halicka, D.H.; Darzynkiewicz, Z. Cell cycle effects and caspase-dependent and independent death of HL-60 and Jurkat cells treated with the inhibitor of NF-kappaB parthenolide. Cell Cycle, 2003, 2(4), 377-383.
308. Pozarowski, P.; Halicka, D.H.; Darzynkiewicz, Z. NF-kappaB inhibitor sesquiterpene parthenolide induces concurrently atypical apoptosis and cell necrosis: difficulties in identification of dead cells in such cultures. Cytometry, 2003, 54(2), 118-124.
309. Lu, C.; Zhou, L.Y.; Xu, H.J.; Chen, X.Y.; Tong, Z.S.; Liu, X.D.; Jia, Y.S.; Chen, Y. RIP3 overexpression sensitizes human breast cancer cells to parthenolide in vitro via intracellular ROS accumulation. Acta Pharmacol. Sin., 2014, 35(7), 929-936.
310. Kong, F.C.; Zhang, J.Q.; Zeng, C.; Chen, W.L.; Ren, W.X.; Yan, G.X.; Wang, H.X.; Li, Q.B.; Chen, Z.C. Inhibitory effects of parthenolide on the activity of NF-κB in multiple myeloma via targeting TRAF6. J. Huazhong Univ. Sci. Technolog. Med. Sci., 2015, 35(3), 343-349.
311. Delmas, D.; Solary, E.; Latruffe, N. Resveratrol, a phytochemical inducer of multiple cell death pathways: apoptosis, autophagy and mitotic catastrophe. Curr. Med. Chem., 2011, 18(8), 1100-1121.
312. Galluzzi, L.; Vitale, I.; Vacchelli, E.; Kroemer, G. Cell death signaling and anticancer therapy. Front. Oncol., 2011, 1, 5.
313. Sperandio, S.; de Belle, I.; Bredesen, D.E. An alternative, nonapoptotic form of programmed cell death. Proc. Natl. Acad. Sci. U. S. A., 2000, 97 (26), 14376-14381.
314. Sperandio, S.; Poksay, K.S.; Schilling, B.; Crippen, D.; Gibson, B.W.; Bredesen, D.E. Identification of new modulators and protein alterations in non-apoptotic programmed cell death. J. Cell. Biochem., 2010, 111 (6), 1401-1412.
315. Guo, W.J.; Chen, T.S.; Wang, X.P.; Chen, R. Taxol induces concentration-dependent apoptotic and paraptosis-like cell death in human lung adenocarcinoma (ASTC-a-1) cells. J. X-ray Sci. Technol., 2010, 18 (3), 293-308.
316. Zhang, J.S.; Li, D.M.; Ma, Y.; He, N.; Gu, Q.; Wang, F.S.; Jiang, S.Q.; Chen, B.Q.; Liu, J.R. γ-Tocotrienol induces paraptosis-like cell death in human colon carcinoma SW620 cells. PLoS One, 2013, 8 (2), e57779.
317. Li, B.; Zhao, J.; Wang, C.Z.; Searle, J.; He, T.C.; Yuan, C.S.; Du, W. Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. Cancer Lett., 2011, 301 (2), 185-192.
318. Wang, Y.; Zhu, X.; Yang, Z.; Zhao, X. Honokiol induces caspaseindependent paraptosis via reactive oxygen species production that is accompanied by apoptosis in leukemia cells. Biochem. Biophys. Res. Communs., 2013, 430 (3), 876-882.
319. Yumnam, S.; Hong, G.E.; Raha, S.; Venkatarame Gowda Saralamma, V.; Lee, H.J.; Lee, W.S.; Kim, E.H.; Kim, G.S. Mitochondrial Dysfunction and Ca(2+) Overload Contributes to Hesperidin Induced Paraptosis in Hepatoblastoma Cells, HepG2. J. Cell. Physiol., 2015, Oct 22.
320. Yoon, M.J.; Lee A.R.; Jeong, S.A.; Kim, Y.S.; Kim, J.Y.; Kwon, Y.J.; Choi, K.S. Release of Ca2+ from the endoplasmic reticulum and its subsequent influx into mitochondria trigger celastrolinduced paraptosis in cancer cells. Oncotarget, 2014, 5(16), 6816-6831.
321. Wang, Y.; Kim, N.S.; Haince, J.F.; Kang, H.C.; David, K.K.; Andrabi, S.A.; Poirier, G.G.; Dawson, V.L.; Dawson, T.M. Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos). Sci. Signal., 2011, 4(167), ra20.
322. Fatokun, A.A.; Dawson, V.L.; Dawson, T.M. Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities. Br. J. Pharmacol., 2014, 171(8), 2000-2016.
323. Aredia, F.; Scovassi, A.I. Involvement of PARPs in cell death. Front. Biosci. (Elite Education), 2014, 6, 308-317.
324. Basello, D.A.; Scovassi, A.I. Poly(ADP-ribosylation) and neurodegenerative disorders. Mitochondrion, 2015, 24, 56-63.
325. Andrabi S.A.; Umanah, G.K.; Chang, C.; Stevens, D.A.; Karuppagounder, S.S.; Gagne, J.P.; Poirier, G.G.; Dawson, V.L.; Dawson, T.M. Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis. Proc. Natl. Acad. Sci. U. S. A., 2014, 111(28), 10209-10214.
326. Zhao, N.; Mao, Y.; Han, G.; Ju, Q.; Zhou, L.; Liu, F.; Xu, Y.; Zhao, X. YM155, a survivin suppressant, triggers PARP-dependent cell death (parthanatos) and inhibits esophageal squamous-cell carcinoma xenografts in mice. Oncotarget, 2015, 6(21),18445-18459.
327. Castedo, M.; Perfettini, J.L.; Roumier, T.; Andreau, K.; Medema, R.; Kroemer, G. Cell death by mitotic catastrophe: a molecular definition. Oncogene, 2004, 23 (16), 2825-2837.
328. Chow, J.P.H.; Poon, R.Y.C. Mitotic catastrophe. Cell Cycle Deregulation in Cancer, 2010, p.79-96. Ed. Greg Enders. Springer, New York.
329. Vakifahmetoglu, H.; Olsson, M.; Zhivotovsky, B. Death through a tragedy: mitotic catastrophe. Cell Death Differ., 2008, 15, 1153-1162.
330. Mc Gee, M.M. Targeting the Mitotic Catastrophe Signaling Pathway in Cancer. Med. Inflamm., 2015, 2015, 146282
331. Chen, C.A.; Chen C.C.; Shen, C.C.; Chang, H.H.; Chen, Y.J. Moscatilin induces apoptosis and mitotic catastrophe in human esophageal cancer cells. J. Med. Food., 2013, 16(10), 869-877.
332. Kainz, K.P.; Krenn, L.; Erdem, Z.; Kaehlig, H.; Zehl, M.; Bursch, W.; Berger, W.; Marian, B. 2-deprenyl-rheediaxanthone B isolated from Metaxya rostrata induces active cell death in colorectal tumor cells. PLoS One, 2013, 8(6), e65745.
333. Dolečkova, I.; Rarova, L.; Gruz, J.; Vondrusova, M.; Strnad, M.; Kryštof, V. Antiproliferative and antiangiogenic effects of flavone eupatorin, an active constituent of chloroform extract of Orthosiphon stamineus leaves. Fitoterapia, 2012, 83(6), 1000-1007.
334. Chen, Y.J.; Chou, C.J.; Chang, T.T. Compound MMH01 possesses toxicity against human leukemia and pancreatic cancer cells. Toxicol. In Vitro, 2009, 23(3), 418-424.
335. Pathak, S.; Multani, A.S.; Banerji, P.; Banerji, P. Ruta 6 selectively induces cell death in brain cancer cells but proliferation in normal peripheral blood lymphocytes: A novel treatment for human brain cancer. Int. J. Oncol., 2003, 23(4), 975-982.
336. Hematulin, A.; Ingkaninan, K.; Limpeanchob, N.; Sagan, D. Ethanolic extract from Derris scandens Benth mediates radiosensitzation via two distinct modes of cell death in human colon cancer HT-29 cells. As. Pac. J. Cancer Prev., 2014, 15(4), 1871-1877.
337. Reyjal, J.; Cormier, K.; Turcotte, S. Autophagy and cell death to target cancer cells: exploiting synthetic lethality as cancer therapies. Adv. Exp. Med. Biol., 2014, 772, 167-188.
338. Fulda, S. Therapeutic exploitation of necroptosis for cancer therapy. Semin. Cell Dev. Biol., 2014, 35, 51-66.
339. Cho, Y.S.; Park, S.Y. Harnessing of Programmed Necrosis for Fighting against Cancers. Biomol. Ther. (Seoul), 2014, 22(3), 167-175.
340. Belaid, A.; Ndiaye, P.D.; Filippakis, H.; Roux, J.; Rottinger, E.; Graba, Y.; Brest, P.; Hofman, P.; Mograbi, B. Autophagy: Moving Benchside Promises to Patient Bedsides. Curr. Cancer Drug Targets, 2015, 15(8), 684-702.
341. Zhang, D.; Tang, B.; Xie, X.; Xiao, Y.F.; Yang, S.M.; Zhang, J.W. The interplay between DNA repair and autophagy in cancer therapy. Cancer Biol. Ther., 2015, 16(7), 1005-1013.
342. Tang, J.; Di, J.; Cao, H.; Bai, J.; Zheng, J. p53-mediated autophagic regulation: A prospective strategy for cancer therapy. Cancer Lett., 2015, 363(2), 101-107.
343. Li, S.; Wang, L.; Hu, Y.; Sheng, R. Autophagy regulators as potential cancer therapeutic agents: a review. Curr. Top. Med. Chem., 2015, 15(8), 720-744.